WO2017150615A1 - Curable composition - Google Patents

Curable composition Download PDF

Info

Publication number
WO2017150615A1
WO2017150615A1 PCT/JP2017/008119 JP2017008119W WO2017150615A1 WO 2017150615 A1 WO2017150615 A1 WO 2017150615A1 JP 2017008119 W JP2017008119 W JP 2017008119W WO 2017150615 A1 WO2017150615 A1 WO 2017150615A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
compound
curable
curable composition
weight
Prior art date
Application number
PCT/JP2017/008119
Other languages
French (fr)
Japanese (ja)
Inventor
坂根正憲
Original Assignee
株式会社ダイセル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社ダイセル filed Critical 株式会社ダイセル
Publication of WO2017150615A1 publication Critical patent/WO2017150615A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/20Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M15/00Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
    • D06M15/19Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
    • D06M15/21Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D06M15/263Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof

Definitions

  • the present invention relates to a light or thermosetting composition.
  • This application claims the priority of Japanese Patent Application No. 2016-039842 for which it applied to Japan on March 2, 2016, and uses the content here.
  • Carbon fibers themselves are small and brittle, but can be reinforced by impregnating a matrix resin such as an epoxy resin or an acrylic resin and then curing the matrix resin.
  • the carbon fiber reinforced carbon fiber reinforced resin or carbon fiber reinforced plastic
  • a sizing agent is used for the purpose of improving the adhesion between the carbon fiber and the matrix resin and imparting excellent mechanical strength (toughness and scratch resistance) to the carbon fiber. .
  • a curable composition containing a compound having a (meth) acryloyloxy group as a radical curable group and a glycidyl group as a cationic curable group has been mainly used (Patent Document 1, etc.). .
  • an object of the present invention is to provide a curable composition that can form a cured product that is excellent in curability, toughness, and scratch resistance.
  • Another object of the present invention is to provide a carbon fiber sizing agent that has excellent curability and can impart excellent toughness and scratch resistance to carbon fibers.
  • a compound having a (meth) acryloyloxy group as a radical curable group and an alicyclic epoxy group as a cationic curable group in one molecule is excellent in curing. And can be cured quickly by light irradiation or heat treatment to form a cured product with excellent toughness and scratch resistance, and a curable composition containing the above compound for carbon fibers. It has been found that when used as a sizing agent, the carbon fiber can be provided with good toughness and scratch resistance with excellent workability. The present invention has been completed based on these findings.
  • this invention is a curable composition containing a curable compound, Comprising: The compound which has an alicyclic epoxy group and (meth) acryloyloxy group in 1 molecule as said curable compound is contained in a curable composition.
  • a curable composition containing 0.1 to 99.9% by weight of the total amount of the curable compound.
  • the present invention also provides the above curable composition, which is a light or thermosetting composition.
  • the compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is represented by the following formula (a-1): (Wherein X represents a single bond or a linking group, and R 1 represents a hydrogen atom or a methyl group)
  • the curable composition is a compound represented by:
  • the present invention also provides the curable composition as described above, which is a sizing agent for carbon fiber.
  • a compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is a compound containing one alicyclic epoxy group and one (meth) acryloyloxy group in one molecule.
  • a compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is represented by formula (a) (wherein ring Z represents an alicyclic ring constituting an alicyclic epoxy group, and X represents a single bond. Or R 1 represents a hydrogen atom or a methyl group, and the curable composition according to [1] or [2].
  • Ring Z in formula (a) contains 3 to 20 membered cycloalkane ring, 3 to 20 membered cycloalkene ring, or bridged ring (preferably 2 to 4 3 to 10 membered rings)
  • the curable composition according to [4] which is a bridge ring).
  • the curable composition according to [1] or [2], wherein the compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is a compound represented by the formula (a-1). object.
  • the curable compound further contains a cationic curable compound (excluding a compound containing a radical curable group) and / or a radical curable compound (excluding a compound containing a cation curable group), [1] The curable composition according to any one of [6].
  • the total content of the cationic curable compound and the radical curable compound is 0.1 to 99.9% by weight of the total amount of the curable compound contained in the curable composition (preferably 5 to 99% by weight,
  • the cationically curable compound is (3,4,3 ′, 4′-diepoxy) bicyclohexyl, bis (3,4-epoxycyclohexylmethyl) ether, 1,2-epoxy-1,2-bis (3 , 4-epoxycyclohexane-1-yl) ethane, 2,2-bis (3,4-epoxycyclohexane-1-yl) propane, 1,2-bis (3,4-epoxycyclohexane-1-yl) ethane,
  • the curable composition according to any one of [7] to [9] which is at least one compound selected from the compounds represented by formulas (b-1) to (b-10): [15]
  • the content of the cationic curable compound preferably an epoxy compound, more preferably an alicyclic epoxy compound, particularly preferably an alicyclic epoxy group-
  • the total amount of the curable compound contained in the curable composition is the total content of the compound having an alicyclic epoxy group and (meth) acryloyloxy group in one molecule, the cationic curable compound, and the radical curable compound.
  • Composition [18]
  • the content of components other than the curable compound, the polymerization initiator, the curing agent, and the curing accelerator is 0.05 to 10% by weight (preferably 0.1 to 5% by weight) of the total amount of the curable composition.
  • a carbon fiber reinforced resin is obtained by applying the curable composition according to any one of [1] to [18] to carbon fiber and then curing the applied curable composition. The manufacturing method of carbon fiber reinforced resin.
  • the curable composition of the present invention includes, as a curable compound, a compound having a (meth) acryloyloxy group as a radical curable group and an alicyclic epoxy group as a cationic curable group in one molecule in a specific range. Since it contains, it is excellent in sclerosis
  • inks for example, 3D printer ink
  • sealants for example, sealants for optical semiconductors
  • an insulating film forming material an adhesive sheet forming material for touch panels, a prepreg forming material, a sizing agent, a matrix resin for carbon fiber reinforced resin, and the like.
  • the curable composition of the present invention is used as a carbon fiber sizing agent or a carbon fiber reinforced resin matrix resin, excellent toughness and scratch resistance can be efficiently imparted to the carbon fiber.
  • the curable composition of the present invention is a curable composition containing a curable compound, and the curable compound includes a compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule (hereinafter, “ At least one of the component (A) ”and the“ alicyclic epoxy group-containing acrylate ”may be contained in an amount of 0.1 to 99.9% by weight of the total amount of the curable compound contained in the curable composition.
  • the curable composition of this invention may contain the below-mentioned component (B) and component (C) other than the said component (A) as a sclerosing
  • Component (A): Alicyclic epoxy group-containing acrylate is a compound having an alicyclic epoxy group as a cationic curable group and a (meth) acryloyloxy group as a radical curable group in one molecule.
  • the “alicyclic epoxy group” is “a group composed of two adjacent carbon atoms and oxygen atoms constituting the alicyclic ring”.
  • (meth) acryloyloxy group” in the present specification refers to an acryloyloxy group and a methacryloyloxy group.
  • the alicyclic epoxy group-containing acrylate of the present invention is particularly preferably a compound containing one alicyclic epoxy group and one (meth) acryloyloxy group in one molecule.
  • an alicyclic epoxy group-containing acrylate represented by the following formula (a) A cyclic epoxy group-containing (meth) acrylate is preferred.
  • the ring Z shows the alicyclic ring which comprises an alicyclic epoxy group
  • X shows a single bond or a coupling group
  • R 1 represents a hydrogen atom or a methyl group.
  • Examples of the alicyclic ring include cycloalkane rings of about 3 to 20 members (preferably 3 to 15 members, particularly preferably 5 to 8 members) such as cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, and cyclooctane.
  • the alicyclic ring may be condensed with an aromatic or non-aromatic heterocyclic ring.
  • the alicyclic ring may have various substituents.
  • substituents include a halogen atom, an oxo group, a hydroxyl group, a substituted oxy group (for example, a C 1-4 alkoxy group, a C 6-10 aryloxy group, a C 7-16 aralkyloxy group, a C 1-4 acyloxy group).
  • carboxyl group substituted oxycarbonyl group (eg C 1-4 alkoxycarbonyl group, C 6-10 aryloxycarbonyl group, C 7-16 aralkyloxycarbonyl group etc.), substituted or unsubstituted carbamoyl group (eg C 1-4 alkyl substituted carbamoyl such as carbamoyl, methyl carbamoyl, C 6-10 aryl substituted carbamoyl group such as phenyl carbamoyl group), cyano group, nitro group, substituted or unsubstituted amino group (eg, methylamino, dimethylamino) , ethylamino, mono- or di-C 1-4 alkylamino group such as a diethylamino group; 1-pyrrolidinyl, Piperi Bruno, cyclic amino group of 5-8 membered, such as a morpholino group; acetylamino, propionylamino, C 1-10
  • the linking group in X is a divalent group having one or more atoms.
  • a divalent hydrocarbon group a carbonyl group (—CO—), an ether bond (—O—), a thioether bond (—S -), An ester bond (-COO-), an amide bond (-CONH-), a carbonate bond (-OCOO-), and a group in which two or more selected from these are bonded.
  • Examples of the divalent hydrocarbon group include 1 to 20 carbon atoms such as a methylene group, a methylmethylene group, a dimethylmethylene group, an ethylene group, a propylene group, and a trimethylene group (preferably 1 to 10, particularly preferably 1 to An alkylene group of about 3); an alkenylene group of about 2 to 20 carbon atoms (preferably 2 to 10, particularly preferably 2 to 4) such as a vinylene group, a propenylene group, or a 1-butenylene group; an ethynylene group, a propynylene group, etc.
  • 1 to 20 carbon atoms such as a methylene group, a methylmethylene group, a dimethylmethylene group, an ethylene group, a propylene group, and a trimethylene group (preferably 1 to 10, particularly preferably 1 to An alkylene group of about 3); an alkenylene group of about 2 to 20 carbon atoms (preferably 2 to 10, particularly preferably 2 to 4) such as
  • alkynylene group having about 2 to 20 carbon atoms preferably 2 to 10, particularly preferably 2 to 3
  • 1,2-cyclopentylene group, 1,3-cyclopentylene group, cyclopentylidene group, 1,2 -C3-20 (preferably 3-3) such as cyclohexylene group, 1,3-cyclohexylene group, 1,4-cyclohexylene group, cyclohexylidene group, etc.
  • 1, particularly preferable examples thereof include such as 3-6) about a cycloalkylene group (including cycloalkylidene group).
  • a compound represented by the following formula (a-1) is preferable from the viewpoint of safety such as sensitization.
  • X and R 1 are the same as described above.
  • a commercially available product such as a trade name “E-DCPA” (a compound in which X in the following formula is a single bond; manufactured by Daicel Corporation) can be suitably used.
  • Component (B) in the present invention is a compound having one or more cationic curable groups in one molecule (excluding compounds containing radical curable groups). These can be used alone or in combination of two or more.
  • the cationic curable group include an epoxy group, an oxetane group, and a vinyl ether group.
  • a compound containing an epoxy group as a cationic curable group, that is, an epoxy compound is preferable from the viewpoint of the balance between the cationic curable property and the physical properties of the obtained cured product.
  • the epoxy compound is a compound having one or more epoxy groups (oxirane rings) in one molecule, such as an alicyclic epoxy compound; an aromatic epoxy compound (for example, bisphenol A type epoxy compound, bisphenol F type epoxy compound). Aromatic glycidyl ether epoxy compounds); aliphatic epoxy compounds; glycidyl ester epoxy compounds; glycidyl amine epoxy compounds; epoxy-modified siloxane compounds and the like.
  • an alicyclic epoxy compound in view of particularly excellent cationic curability.
  • the alicyclic epoxy compound includes the following compounds (i) to (iii).
  • (I) Compound having an alicyclic epoxy group (hereinafter sometimes referred to as “alicyclic epoxy group-containing compound”)
  • the above compound (i), that is, an alicyclic epoxy group-containing compound is particularly preferable.
  • the alicyclic epoxy group-containing compound among them, a compound having a cyclohexene oxide group is preferable in that a cured product particularly excellent in toughness and scratch resistance is obtained, and particularly represented by the following formula (b). Compounds are preferred.
  • Y shows a single bond or a coupling group.
  • the linking group include a divalent hydrocarbon group, an alkenylene group in which part or all of a carbon-carbon double bond is epoxidized, a carbonyl group (—CO—), an ether bond (—O—), Examples include an ester bond (—COO—), a carbonate group (—O—CO—O—), an amide group (—CONH—), and a group in which a plurality of these are linked.
  • the cyclohexene oxide group in the formula (b) may have a substituent such as a C 1-5 alkyl group.
  • divalent hydrocarbon group examples include the same examples as the divalent hydrocarbon group in X.
  • the divalent hydrocarbon group may be any of various substituents [eg, halogen atom, oxo group, hydroxyl group, carboxyl group, substituted or unsubstituted carbamoyl group, cyano group, nitro group, substituted or unsubstituted amino group, sulfo group. Group, epoxy group, heterocyclic group, etc.].
  • the hydroxyl group and carboxyl group may be protected with a protective group commonly used in the field of organic synthesis.
  • alkenylene group in the alkenylene group in which part or all of the carbon-carbon double bond is epoxidized include, for example, vinylene group, propenylene group, 1-butenylene group And straight-chain or branched alkenylene groups having 2 to 8 carbon atoms such as 2-butenylene group, butadienylene group, pentenylene group, hexenylene group, heptenylene group, octenylene group and the like.
  • the epoxidized alkenylene group is preferably an alkenylene group in which all of the carbon-carbon double bonds are epoxidized, more preferably 2 to 4 carbon atoms in which all of the carbon-carbon double bonds are epoxidized. Alkenylene group.
  • alicyclic epoxy group-containing compound examples include, for example, (3,4,3 ′, 4′-diepoxy) bicyclohexyl, bis (3,4-epoxycyclohexylmethyl) ether, 1,2-epoxy. -1,2-bis (3,4-epoxycyclohexane-1-yl) ethane, 2,2-bis (3,4-epoxycyclohexane-1-yl) propane, 1,2-bis (3,4-epoxy) And cyclohexane-1-yl) ethane and compounds represented by the following formulas (b-1) to (b-10). In the following formulas (b-5) and (b-7), n 1 and n 2 each represents an integer of 1 to 30.
  • L in the following formula (b-5) is an alkylene group having 1 to 8 carbon atoms, for example, methylene group, ethylene group, propylene group, isopropylene group, butylene group, isobutylene group, s-butylene group, pentylene group.
  • a linear or branched alkylene group such as a hexylene group, a heptylene group, and an octylene group.
  • linear or branched alkylene groups having 1 to 3 carbon atoms such as a methylene group, an ethylene group, a propylene group, and an isopropylene group are preferable.
  • N 3 to n 8 in the following formulas (b-9) and (b-10) each represents an integer of 1 to 30.
  • Examples of the compound (ii) in which the epoxy group is directly bonded to the alicyclic ring with a single bond include a compound represented by the following formula (b2).
  • R ′′ is a group obtained by removing p OH groups from the structural formula of the p-valent alcohol, and p and n each represent a natural number.
  • the p-valent alcohol [R ′′-(OH) p ] Includes, for example, polyhydric alcohols such as 2,2-bis (hydroxymethyl) -1-butanol (alcohols having 1 to 15 carbon atoms, etc.).
  • p is preferably 1 to 6
  • n is preferably 1 to 30.
  • ns in the respective groups within [] (inside the outer parentheses) may be the same or different.
  • Examples of the (iii) hydrogenated aromatic glycidyl ether-based epoxy compound include 2,2-bis [4- (2,3-epoxypropoxy) cyclohexyl] propane, 2,2-bis [3,5- A compound obtained by hydrogenating a bisphenol A type epoxy compound such as dimethyl-4- (2,3-epoxypropoxy) cyclohexyl] propane (nuclear hydrogenated bisphenol A type epoxy compound); bis [o, o- (2,3 -Epoxypropoxy) cyclohexyl] methane, bis [o, p- (2,3-epoxypropoxy) cyclohexyl] methane, bis [p, p- (2,3-epoxypropoxy) cyclohexyl] methane, Bisphenol F type epoxy compounds such as bis [3,5-dimethyl-4- (2,3-epoxypropoxy) cyclohexyl] methane Compound (nuclear hydrogenated bisphenol F type epoxy compound); hydrogen
  • Component (C) in the present invention is a compound having one or more radical curable groups (for example, (meth) acryloyloxy group, vinyl group, vinyl ether group, etc.) in the molecule (compound containing a cationic curable group) Except). These can be used alone or in combination of two or more.
  • radical curable groups for example, (meth) acryloyloxy group, vinyl group, vinyl ether group, etc.
  • radical curable compound examples include (meth) acryl such as methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, butyl (meth) acrylate, pentyl (meth) acrylate, and hexyl (meth) acrylate.
  • Acid alkyl ester [eg (meth) acrylic acid C 1-10 alkyl ester, etc.]; benzyl (meth) acrylate, cyclohexyl (meth) acrylate, cyclopentyl (meth) acrylate, adamantyl (meth) acrylate, cyclopentenyl (meth) acrylate , Isobornyl (meth) acrylate, dicyclopentanyl (meth) acrylate, dicyclopentenyl (meth) acrylate, 2- (dicyclopentenyloxy) ethyl (meth) acrylate, 2- (disicyl) (Meth) acrylic acid ester having a cyclic structure (aliphatic cyclic structure or aromatic cyclic structure) in the molecule such as pentanyloxy) ethyl (meth) acrylate; styrene, vinyltoluene, ⁇ -methylstyrene, vinylnaphthal
  • Styrenic compounds such as methyl vinyl ether, butyl vinyl ether, and phenyl vinyl ether, and derivatives thereof (for example, compounds in which substituents such as a hydroxyl group, a carboxyl group, a quaternary ammonium group, an amino group, and a heterocyclic group are bonded. And the like.
  • the curable composition of the present invention preferably contains one or more selected from a polymerization initiator, a curing agent, and a curing accelerator together with the above-described curable compound.
  • a polymerization initiator preferably contains a radical polymerization initiator and a cationic polymerization initiator) or a curing agent and a curing accelerator.
  • the polymerization initiator includes a radical photopolymerization initiator, a thermal radical polymerization initiator, a cationic photopolymerization initiator, and a thermal cationic polymerization initiator.
  • Photo radical polymerization initiator examples include benzophenone, acetophenone benzyl, benzyl dimethyl ketone, benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, dimethoxyacetophenone, dimethoxyphenylacetophenone, diethoxyacetophenone, diphenyl disulfite, Orthobenzoyl methyl benzoate, ethyl 4-dimethylaminobenzoate (Nippon Kayaku Co., Ltd., trade name “Kayacure EPA”, etc.), 2,4-diethylthioxanthone (Nippon Kayaku Co., Ltd., trade name) “Kayacure DETX” etc.), 2-methyl-1- [4- (methyl) phenyl] -2-morpholinopropanone-1 (manufactured by BASF, trade name “Irgacure
  • thermal radical polymerization initiator examples include azo compounds such as azobisisobutyronitrile, hydroperoxide, dialkyl peroxide, peroxyester, diacyl peroxide, peroxydicarbonate, peroxyketal, and ketone peroxide.
  • Oxides (specifically, benzoyl peroxide, t-butylperoxy-2-ethylhexanoate, 2,5-dimethyl-2,5-di (2-ethylhexanoyl) peroxyhexane, t-butyl Peroxybenzoate, t-butyl peroxide, cumene hydroperoxide, dicumyl peroxide, di-t-butyl peroxide, 2,5-dimethyl-2,5-dibutylperoxyhexane, 2,4-dichlorobenzoylper Oxide, 1,4-di (2- -Butylperoxyisopropyl) benzene, 1,1-bis (t-butylperoxy) -3,3,5-trimethylcyclohexane, methyl ethyl ketone peroxide, 1,1,3,3-tetramethylbutylperoxy-2- And organic peroxides such as ethylhexanoate).
  • the cationic photopolymerization initiator is a compound that generates an acid upon irradiation with light and initiates a curing reaction of the cationic curable compound contained in the curable composition, and includes a cation moiety that absorbs light and a source of acid generation. It consists of the anion part.
  • Examples of the cationic photopolymerization initiator include diazonium salt compounds, iodonium salt compounds, sulfonium salt compounds, phosphonium salt compounds, selenium salt compounds, oxonium salt compounds, ammonium salt compounds, bromine salt compounds, and the like. Among them, it is preferable to use a sulfonium salt compound in that a cured product having excellent curability can be formed.
  • Examples of the cation moiety of the sulfonium salt compound include (4-hydroxyphenyl) methylbenzylsulfonium ion, triphenylsulfonium ion, diphenyl [4- (phenylthio) phenyl] sulfonium ion, and 4- (4-biphenylylthio) phenyl.
  • Examples thereof include arylsulfonium ions such as -4-biphenylylphenylsulfonium ion and tri-p-tolylsulfonium ion (particularly, triarylsulfonium ion).
  • Y represents a phenyl group or a biphenylyl group.
  • Phf represents at least one hydrogen atom
  • BF 4 ⁇ [(Rf) t PF 6-t ] - (Rf: an alkyl group in which 80% or more of hydrogen atoms are substituted with fluorine atoms, t: an integer of 0 to 5), AsF 6 ⁇ , SbF 6 ⁇ , SbF 5 OH ⁇ and the like. it can.
  • Examples of the cationic photopolymerization initiator include (4-hydroxyphenyl) methylbenzylsulfonium tetrakis (pentafluorophenyl) borate, 4- (4-biphenylylthio) phenyl-4-biphenylylphenylsulfonium tetrakis (pentafluorophenyl) Borate, 4- (phenylthio) phenyldiphenylsulfonium phenyltris (pentafluorophenyl) borate, [4- (4-biphenylylthio) phenyl] -4-biphenylylphenylsulfonium phenyltris (pentafluorophenyl) borate, diphenyl [4 -(Phenylthio) phenylsulfonium] hexafluoroantimonate, diphenyl [4- (phenylthio) pheny
  • Thermal cationic polymerization initiator is a compound that generates an acid by heat treatment and initiates a curing reaction of the cationic curable compound contained in the curable composition, and a cationic part that absorbs heat and a source of the acid It consists of an anion part.
  • thermal cationic polymerization initiator examples include iodonium salt compounds and sulfonium salt compounds.
  • Examples of the cationic part of the thermal cationic polymerization initiator include 4-hydroxyphenyl-methyl-benzylsulfonium ion, 4-hydroxyphenyl-methyl- (2-methylbenzyl) sulfonium ion, 4-hydroxyphenyl-methyl-1-naphthyl. Examples include methylsulfonium ion and p-methoxycarbonyloxyphenyl-benzyl-methylsulfonium ion.
  • Examples of the anion portion of the thermal cationic polymerization initiator include the same examples as the anion portion of the photocationic polymerization initiator.
  • thermal cationic polymerization initiator examples include 4-hydroxyphenyl-methyl-benzylsulfonium phenyltris (pentafluorophenyl) borate, 4-hydroxyphenyl-methyl- (2-methylbenzyl) sulfonium phenyltris (pentafluorophenyl) borate 4-hydroxyphenyl-methyl-1-naphthylmethylsulfonium, phenyltris (pentafluorophenyl) borate, p-methoxycarbonyloxyphenyl-benzyl-methylsulfonium, phenyltris (pentafluorophenyl) borate, and the like. These can be used alone or in combination of two or more.
  • the curing agent in the present invention is a compound that reacts with a compound having an epoxy group (particularly, an alicyclic epoxy group) to form a crosslinked structure by heat treatment.
  • a compound having an epoxy group particularly, an alicyclic epoxy group
  • an acid anhydride, an imidazole compound, an amine examples thereof include compounds, polyamide resins, polysulfide resins, and latent curing agents. These can be used alone or in combination of two or more.
  • Examples of the acid anhydride include methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, dodecenyl succinic anhydride, methylendomethylenetetrahydrophthalic anhydride, hydrogenated methylnadic acid anhydride, methylheimic acid anhydride, Trialkyltetrahydrophthalic anhydride maleic acid adduct, phthalic anhydride, tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methylcyclohexenedicarboxylic anhydride, and derivatives thereof (for example, a substituent such as an alkyl group is bonded to the ring) Etc.).
  • an anhydride of a saturated monocyclic hydrocarbon dicarboxylic acid or a derivative thereof is particularly preferable from the viewpoint of transparency and light resistance of the cured product.
  • an acid anhydride that is liquid at 25 ° C. for example, hydrogenated methylnadic acid anhydride, methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, dodecenyl succinic anhydride, Methyl endomethylenetetrahydrophthalic anhydride and the like are preferable, and hydrogenated methyl nadic acid anhydride is particularly preferable.
  • Examples of the acid anhydride include a product name “Licacid MH-700” (manufactured by Shin Nippon Rika Co., Ltd.), a product name “Rikacid MH-700F” (manufactured by Shin Nippon Rika Co., Ltd.) and a product name “HN-5500 ”(Manufactured by Hitachi Chemical Co., Ltd.) can be used.
  • imidazole compound examples include 2-methylimidazole, 2-ethyl-4-methylimidazole, 1-cyanoethyl-2-undecylimidazolium tolmellitate, and the like.
  • Examples of the amine compound include piperidine, N, N-dimethylpiperazine, triethylenediamine, 2,4,6-tris (dimethylaminomethyl) phenol, benzyldimethylamine, 2- (dimethylaminomethyl) phenol, diethylenetriamine, and diethylamino.
  • Examples include propylamine, xylenediamine, metaphenylenediamine, diaminodiphenylmethane, and diaminodiphenylsulfone.
  • latent curing agent e.g., boron trifluoride - amine complex, dicyandiamide, organic acid hydrazide, SbF 6 - aromatic sulfonium salts (e.g., trade name "San-Aid SI-100L”, “San-Aid SI-60L” , “Sun-Aid SI-80L”, “Sun-Aid SI-110”, “Sun-Aid SI-180”, Sanshin Chemical Industry Co., Ltd.) and the like.
  • SbF 6 - aromatic sulfonium salts e.g., trade name "San-Aid SI-100L", “San-Aid SI-60L” , “Sun-Aid SI-80L”, “Sun-Aid SI-110”, “Sun-Aid SI-180”, Sanshin Chemical Industry Co., Ltd.
  • the curing accelerator in the present invention is a compound that promotes the reaction between a curing agent and a compound having an epoxy group (particularly an alicyclic epoxy group), and exhibits an effect of quickly curing at a milder temperature.
  • curing accelerator examples include trade names “U-CAT SA 506”, “U-CAT SA 102”, “U-CAT 5003”, “U-CAT 18X”, “U-CAT 12XD” (developed product). (San Apro Co., Ltd.), TPP-K, TPP-MK (Hokuko Chemical Co., Ltd.), PX-4ET (Nippon Chemical Co., Ltd.), 2E4MZ ”(Manufactured by Shikoku Kasei Kogyo Co., Ltd.) can be used.
  • the curable composition of the present invention may contain one or more other components as necessary in addition to the above components.
  • other components include sensitizers, sensitizers, antioxidants, stabilizers, surfactants, solvents, leveling agents, silane coupling agents, fillers, polymerization inhibitors, light stabilizers, Examples thereof include a plasticizer, an antifoaming agent, a foaming agent, an ultraviolet absorber, an ion adsorbent, a pigment, a phosphor, and a release agent.
  • These contents are, for example, about 0.05 to 10% by weight, preferably 0.1 to 5% by weight, based on the total amount (100% by weight) of the curable composition. .
  • the curable composition of the present invention comprises a component (A) and, if necessary, a component (B), a component (C), a component (D), and other components, a self-revolving stirring deaerator, a homogenizer , A planetary mixer, a three-roll mill, a bead mill, and the like. Each component may be mixed simultaneously or sequentially.
  • the content of the component (A) (preferably the compound represented by the formula (a), particularly preferably the compound represented by the formula (a-1)) (the total amount when containing two or more) is the present invention.
  • 0.1 to 99.9% by weight of the total amount (100% by weight) of the curable compound contained in the curable composition preferably 1 to 95% by weight, more preferably 2 to 90% by weight, and particularly preferably 30 to 90% by weight, most preferably 60 to 90% by weight.
  • the curable composition of this invention contains a component (A) in the said range, it can be excellent in sclerosis
  • the content of the component (A) is less than the above range, the adhesion to the substrate tends to decrease, and if the content of the component (A) exceeds the above range, the toughness and scratch resistance are high. There is a tendency to decrease.
  • the curable composition of the present invention comprises component (A) and component (B) (preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound) and / or component (C).
  • component (B) and component (C) preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound
  • component (C) preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound
  • component (C) preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound
  • component (C) preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound
  • component (C) preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound
  • component (C) preferably an epoxy compound,
  • the weight ratio of the content of component (A) in the curable composition of the present invention and the total content of component (B) and component (C) [component (A) / (component (B) + component (C ))] Is, for example, 95/5 to 60/40, preferably 95/5 to 70/30, particularly preferably 90/10 to 75/25.
  • the curable composition of the present invention contains the component (A), the component (B), and the component (C) in the above range, a cured product having excellent curability and excellent toughness and scratch resistance is formed. Can do.
  • component (B) (preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound) in the total amount (100% by weight) of the curable compound contained in the curable composition of the present invention. ) (When two or more types are contained, the total amount thereof) is, for example, 0.1 to 99.9% by weight, preferably 5 to 99% by weight, more preferably 10 to 90% by weight, and particularly preferably 10 to 90% by weight. 70% by weight, most preferably 10-40% by weight.
  • component (B) preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound
  • component (C) contained in the curable composition of the present invention.
  • the proportion of component (B) in is, for example, 60% by weight or more, preferably 80% by weight or more, and particularly preferably 90% by weight or more.
  • the ratio of the total content of component (A), component (B) and component (C) in the total amount (100% by weight) of the curable compound contained in the curable composition of the present invention is, for example, 60% by weight or more, preferably Is 70% by weight or more, particularly preferably 80% by weight or more, most preferably 90% by weight or more, and particularly preferably 95% by weight or more.
  • the upper limit is 100% by weight.
  • the curable composition of this invention may contain curable compounds other than a component (A), a component (B), and a component (C), the content is curable compound whole quantity (100 % By weight), for example, 40% by weight or less, preferably 30% by weight or less, particularly preferably 20% by weight or less, most preferably 10% by weight or less, and particularly preferably 5% by weight or less.
  • the content of the radical polymerization initiator in the case where the curable composition of the present invention contains a polymerization initiator is the radical curable group contained in the curable composition of the present invention.
  • 0.1 to 10.0 parts by weight, preferably 0.1 to 5.0 parts by weight, per 100 parts by weight of the total amount of the compound having (preferably, the total amount of component (A) and component (C)) Particularly preferably 0.2 to 3.0 parts by weight, and most preferably 0.2 to 1.0 parts by weight.
  • all radical curable groups contained in the curable composition are contained. It is preferable to contain it in a proportion of 0.001 to 0.1 equivalent per equivalent of radical curable group (preferably (meth) acryloyloxy group) in the compound.
  • the content of the cationic polymerization initiator in the case where the curable composition of the present invention contains a polymerization initiator is the cationic curable group contained in the curable composition.
  • Particularly preferred is 0.2 to 3.0 parts by weight, and most preferred is 0.2 to 1.0 part by weight. More specifically, it has all the cationic curable groups contained in the curable composition.
  • cationically curable group preferably epoxy group
  • content of a cationic polymerization initiator is less than the said range, there exists a tendency for sclerosis
  • content of the cationic polymerization initiator exceeds the above range, particularly when the curable composition of the present invention is a photocurable composition, internal cured defects tend to occur easily in the obtained cured product. is there.
  • the content of the acid anhydride (the total amount when two or more types are contained) is the cation curable contained in the curable composition.
  • the cation curable contained in the curable composition For example, 50 to 200 parts by weight, preferably 100 to 145 parts by weight, more specifically, with respect to 100 parts by weight of the total amount of the compound having a group (preferably the total amount of component (A) and component (B))
  • the ratio of the acid anhydride group to 0.5 to 1.5 equivalents per equivalent of the cationically curable group (preferably epoxy group) in the compound having all the cationic curable groups contained in the curable composition It is preferable to contain.
  • the content of the acid anhydride is less than 50 parts by weight, the curing becomes insufficient and the toughness of the resulting cured product tends to decrease. On the other hand, if the content of the acid anhydride exceeds 200 parts by weight, the cured product may be colored to deteriorate the hue.
  • the content of the latent curing agent (the total amount when containing two or more types) is the cation contained in the curable composition.
  • Particularly preferred is 1 to 5 parts by weight.
  • the content of the latent curing agent is less than 0.1 parts by weight, curing becomes insufficient, and the toughness of the obtained cured product tends to decrease.
  • the content of the latent curing agent exceeds 5 parts by weight, the cured product may be colored to deteriorate the hue.
  • the curable composition of this invention contains a hardening
  • a hardening accelerator the total amount when it contains 2 or more types
  • content of the hardening accelerator is curable.
  • 0.05 to 5 parts by weight, preferably 0 with respect to 100 parts by weight of the total amount of compounds having a cationically curable group contained in the composition preferably the total amount of components (A) and (B)) 0.1 to 3 parts by weight, more preferably 0.2 to 3 parts by weight, particularly preferably 0.2 to 2.5 parts by weight, and most preferably 0.2 to 1.0 parts by weight.
  • the curing accelerator is contained in the range of 0.05 parts by weight or more, an excellent curing acceleration effect can be obtained.
  • a hardening accelerator is contained in 5 weight part or less, coloring of hardened
  • the curable composition of the present invention is excellent in curability and can quickly form a cured product by light irradiation or heat treatment.
  • a cured product can be formed by irradiating active energy rays such as ultraviolet rays.
  • active energy ray in addition to ultraviolet rays, for example, visible rays, infrared rays, X rays, ⁇ rays, ⁇ rays, ⁇ rays, electron rays, and the like can be used. Irradiation conditions can be appropriately changed according to the thickness of the applied curable composition.
  • the wavelength of the active energy ray is usually in the range of 200 to 600 nm, and a wavelength with high sensitivity can be appropriately selected and used according to the type of the photocationic polymerization initiator.
  • a high-pressure mercury lamp, an ultra-high pressure mercury lamp, a xenon lamp, a carbon arc, a metal halide lamp, sunlight, or the like can be used as the ultraviolet irradiation source.
  • the irradiation amount is preferably within a range where the dose is 50 to 2000 mJ / cm 2 .
  • heat treatment may be performed as necessary.
  • unreacted substances in the curable composition can be reduced, and in the case of molding, distortion generated by the molding can be reduced.
  • the heating can be performed, for example, at an ambient temperature of 100 to 200 ° C. for 1 to 120 minutes.
  • a cured product can be formed by heat treatment.
  • the heat treatment temperature is, for example, 40 to 250 ° C.
  • the heat treatment time is, for example, 30 minutes to 12 hours. Further, the heat treatment may be performed at the same temperature, or may be performed by changing the temperature stepwise.
  • the cured product of the curable composition of the present invention is excellent in toughness and scratch resistance, and the pencil hardness (pencil hardness test; conforming to JIS K 5600-5-4) is, for example, H or more, preferably 2H or more.
  • the curable composition of the present invention is excellent in curability as described above, and can be quickly cured by light irradiation and / or heat treatment to form a cured product having excellent toughness and scratch resistance. . Therefore, the curable composition of the present invention is used for, for example, paints, inks (for example, 3D printer ink), adhesives, sealants (for example, optical semiconductor sealants), LSIs, and multilayer printed wiring boards.
  • Interlayer insulating film forming material adhesive sheet forming material for touch panel, prepreg forming material, sizing agent, matrix resin for carbon fiber reinforced resin, resist, sealant, optical material (for example, laminate, transparent substrate, transparent sheet, transparent film) , Optical elements (for example, optical lenses), stereolithography, electronic paper, touch panels, solar cell substrates, optical waveguides, light guide plates, holographic memory, etc., can be used in a wide range of applications.
  • the sizing agent of this invention consists of the above-mentioned curable composition containing a component (A) at least. Since the sizing agent of the present invention has the above-described configuration, it has excellent interfacial adhesion between the carbon fiber and the matrix resin, and by applying the sizing agent of the present invention to the carbon fiber and then curing, the toughness excellent in the carbon fiber. And scratch resistance can be efficiently imparted with excellent workability.
  • Example 1 A curable composition was prepared according to the formulation (unit: parts by weight) described in the following table.
  • the obtained curable composition was applied to a base material (aluminum plate treated with chromium phosphate) so as to have a film thickness of 10 ⁇ m, and was irradiated with ultraviolet rays (dose; 1100 mJ / cm 2) using a high-pressure mercury lamp. 2 ) to obtain a cured coating film (cured product).
  • the pencil hardness of the obtained cured coating film was evaluated by a method according to JIS K5600-5-4.
  • Examples 2-3 and Comparative Example 1 A curable composition was prepared in the same manner as in Example 1 except that the formulation shown in the following table was changed to obtain a cured coating film. In Examples 2 and 3, heat treatment was performed at 150 ° C. for 2 hours instead of ultraviolet irradiation.
  • EDCPA 3,4-epoxytricyclo [5.2.1.0 2,6 ] decan-9-yl acrylate represented by the following formula (a-1-1), trade name “E-DCPA”, Made by Daicel Corporation
  • GMA Glycidyl methacrylate
  • Blenmer G manufactured by NOF Corporation
  • Celoxide 2021P 3,4-epoxycyclohexylmethyl (3,4-epoxy) cyclohexanecarboxylate, trade name “Celoxide 2021P”, manufactured by Daicel Corporation ⁇ polymerization initiator>
  • Irgacure184 Photoradical polymerization initiator, 1-hydroxy-cyclohexyl phenyl ketone, trade name “Irgacure184”, BASF
  • CPI-101A Photocationic polymerization initiator, diphenyl [4- (phenylthio) phenyl] sulfonium hex
  • U-CAT 12XD Epoxy resin curing accelerator, special amine, manufactured by San Apro Co., Ltd. 2E4MZ: Epoxy resin curing accelerator, 2-ethyl-4-methylimidazole, manufactured by Shikoku Kasei Kogyo Co., Ltd.
  • the curable composition of the present invention is particularly excellent in curability, and can be quickly cured by light irradiation or heat treatment to form a cured product having excellent toughness and scratch resistance. Therefore, paints, inks, adhesives, sealants, interlayer insulating film forming materials used for LSIs and multilayer printed wiring boards, touch panel adhesive sheet forming materials, prepreg forming materials, sizing agents, matrix resins for carbon fiber reinforced resins, etc. Can be suitably used.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Epoxy Resins (AREA)

Abstract

Provided is a curable composition that has excellent curability and can form a cured product having excellent toughness and abrasion resistance. The curable composition of the present invention contains a curable compound. As the curable compound, the curable composition contains 0.1-99.9 wt% of a compound having an alicyclic epoxy group and a (meth)acryloyloxy group per molecule of the total curable compound that is contained in the curable composition. As the compound having an alicyclic epoxy group and a (meth)acryloyloxy group per molecule, the compound represented by formula (a-1) is preferable.

Description

硬化性組成物Curable composition
 本発明は、光又は熱硬化性組成物に関する。本願は、2016年3月2日に日本に出願した、特願2016-039842号の優先権を主張し、その内容をここに援用する。 The present invention relates to a light or thermosetting composition. This application claims the priority of Japanese Patent Application No. 2016-039842 for which it applied to Japan on March 2, 2016, and uses the content here.
 炭素繊維は、それ自体は伸縮性が小さく脆いものであるが、例えばエポキシ樹脂、アクリル樹脂などのマトリックス樹脂を含浸させた後、当該マトリックス樹脂を硬化させることで強化することができ、このようにして強化された炭素繊維(炭素繊維強化樹脂、若しくは炭素繊維強化プラスチック)は、自動車部材、航空機部材等として用いられる。そして、炭素繊維を強化する際に、炭素繊維とマトリックス樹脂との接着性を向上させ、炭素繊維に優れた機械的強度(強靱性や耐擦傷性)を付与する目的でサイジング剤が使用される。 Carbon fibers themselves are small and brittle, but can be reinforced by impregnating a matrix resin such as an epoxy resin or an acrylic resin and then curing the matrix resin. The carbon fiber reinforced (carbon fiber reinforced resin or carbon fiber reinforced plastic) is used as an automobile member, an aircraft member, or the like. Then, when reinforcing the carbon fiber, a sizing agent is used for the purpose of improving the adhesion between the carbon fiber and the matrix resin and imparting excellent mechanical strength (toughness and scratch resistance) to the carbon fiber. .
 サイジング剤としては、ラジカル硬化性基としての(メタ)アクリロイルオキシ基とカチオン硬化性基としてのグリシジル基とを有する化合物を含有する硬化性組成物が主に用いられてきた(特許文献1等)。 As the sizing agent, a curable composition containing a compound having a (meth) acryloyloxy group as a radical curable group and a glycidyl group as a cationic curable group has been mainly used (Patent Document 1, etc.). .
特開2005-226193号公報JP 2005-226193 A
 しかし、ラジカル硬化性基としての(メタ)アクリロイルオキシ基とカチオン硬化性基としてのグリシジル基とを有する化合物は硬化の進行が遅いため、十分に硬化させるためには時間がかかり、作業性が悪いこと、得られる硬化物は強靱性及び耐擦傷性の点で十分でないことが問題であった。 However, since a compound having a (meth) acryloyloxy group as a radical curable group and a glycidyl group as a cationic curable group has a slow progress of curing, it takes time to sufficiently cure and the workability is poor. The problem is that the resulting cured product is not sufficient in terms of toughness and scratch resistance.
 従って、本発明の目的は、硬化性に優れ、強靱性、耐擦傷性に優れた硬化物を形成することができる硬化性組成物を提供することにある。
 本発明の他の目的は、硬化性に優れ、炭素繊維に、優れた強靱性、及び耐擦傷性を付与することができる炭素繊維用サイジング剤を提供することにある。
Accordingly, an object of the present invention is to provide a curable composition that can form a cured product that is excellent in curability, toughness, and scratch resistance.
Another object of the present invention is to provide a carbon fiber sizing agent that has excellent curability and can impart excellent toughness and scratch resistance to carbon fibers.
 本発明者は上記課題を解決するため鋭意検討した結果、1分子中にラジカル硬化性基としての(メタ)アクリロイルオキシ基とカチオン硬化性基としての脂環エポキシ基とを有する化合物は優れた硬化性を有し、光照射又は加熱処理を施すことにより速やかに硬化して、強靱性、耐擦傷性に優れた硬化物を形成することができること、前記化合物を含む硬化性組成物を炭素繊維用サイジング剤として用いると、優れた作業性で、炭素繊維に良好な強靱性及び耐擦傷性を付与することができることを見いだした。本発明はこれらの知見に基づいて完成させたものである。 As a result of diligent studies to solve the above problems, the present inventors have found that a compound having a (meth) acryloyloxy group as a radical curable group and an alicyclic epoxy group as a cationic curable group in one molecule is excellent in curing. And can be cured quickly by light irradiation or heat treatment to form a cured product with excellent toughness and scratch resistance, and a curable composition containing the above compound for carbon fibers. It has been found that when used as a sizing agent, the carbon fiber can be provided with good toughness and scratch resistance with excellent workability. The present invention has been completed based on these findings.
 すなわち、本発明は硬化性化合物を含む硬化性組成物であって、前記硬化性化合物として、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物を、硬化性組成物に含まれる硬化性化合物全量の0.1~99.9重量%含有する硬化性組成物を提供する。 That is, this invention is a curable composition containing a curable compound, Comprising: The compound which has an alicyclic epoxy group and (meth) acryloyloxy group in 1 molecule as said curable compound is contained in a curable composition. Provided is a curable composition containing 0.1 to 99.9% by weight of the total amount of the curable compound.
 本発明は、また、光又は熱硬化性組成物である、前記の硬化性組成物を提供する。 The present invention also provides the above curable composition, which is a light or thermosetting composition.
 本発明は、また、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物が、下記式(a-1)
Figure JPOXMLDOC01-appb-C000002
(式中、Xは単結合又は連結基を示し、R1は水素原子又はメチル基を示す)
で表される化合物である前記の硬化性組成物を提供する。
In the present invention, the compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is represented by the following formula (a-1):
Figure JPOXMLDOC01-appb-C000002
(Wherein X represents a single bond or a linking group, and R 1 represents a hydrogen atom or a methyl group)
The curable composition is a compound represented by:
 本発明は、また、炭素繊維用サイジング剤である、前記の硬化性組成物を提供する。 The present invention also provides the curable composition as described above, which is a sizing agent for carbon fiber.
 すなわち、本発明は以下に関する。
[1] 硬化性化合物を含む硬化性組成物であって、前記硬化性化合物として、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物を、硬化性組成物に含まれる硬化性化合物全量の0.1~99.9重量%含有する硬化性組成物。
[2] 光又は熱硬化性組成物である、[1]に記載の硬化性組成物。
[3] 1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物が、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を1個ずつ含有する化合物である、[1]又は[2]に記載の硬化性組成物。
[4] 1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物が、式(a)(式中、環Zは脂環エポキシ基を構成する脂環を示し、Xは単結合又は連結基を示す。R1は水素原子又はメチル基を示す)で表される化合物である、[1]又は[2]に記載の硬化性組成物。
[5] 式(a)中の環Zが3~20員のシクロアルカン環、3~20員のシクロアルケン環、又は橋かけ環(好ましくは、3~10員の環を2~4個含む橋かけ環)である、[4]に記載の硬化性組成物。
[6] 1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物が、式(a-1)で表される化合物である、[1]又は[2]に記載の硬化性組成物。
[7] 硬化性化合物として、更に、カチオン硬化性化合物(ラジカル硬化性基を含む化合物は除く)及び/又はラジカル硬化性化合物(カチオン硬化性基を含む化合物は除く)を含有する、[1]~[6]の何れか1つに記載の硬化性組成物。
[8] 前記カチオン硬化性化合物及び前記ラジカル硬化性化合物の合計含有量が、硬化性組成物に含まれる硬化性化合物全量の0.1~99.9重量%(好ましくは5~99重量%、より好ましくは10~98重量%、特に好ましくは10~70重量%、最も好ましくは10~40重量%)である、[7]に記載の硬化性組成物。
[9] 1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物の含有量と、前記カチオン硬化性化合物と前記ラジカル硬化性化合物との合計含有量の重量比(前者/後者)が95/5~60/40(好ましくは95/5~70/30、特に好ましくは90/10~75/25)である、[7]又は[8]に記載の硬化性組成物。
[10] 前記カチオン硬化性化合物がエポキシ化合物である、[7]~[9]の何れか1つに記載の硬化性組成物。
[11] 前記カチオン硬化性化合物が(i)脂環エポキシ基(=脂環を構成する隣り合う2つの炭素原子と酸素原子とで構成される基、好ましくはシクロヘキセンオキシド基)含有化合物、(ii)脂環にエポキシ基が直接単結合で結合している化合物、及び(iii)水素化芳香族グリシジルエーテル系エポキシ化合物から選択される少なくとも1種の脂環式エポキシ化合物である、[7]~[9]の何れか1つに記載の硬化性組成物。
[12] 前記カチオン硬化性化合物が脂環エポキシ基含有化合物である、[7]~[9]の何れか1つに記載の硬化性組成物。
[13] 前記カチオン硬化性化合物が式(b)で表される化合物である、[7]~[9]の何れか1つに記載の硬化性組成物。
[14] 前記カチオン硬化性化合物が(3,4,3’,4’-ジエポキシ)ビシクロヘキシル、ビス(3,4-エポキシシクロヘキシルメチル)エーテル、1,2-エポキシ-1,2-ビス(3,4-エポキシシクロヘキサン-1-イル)エタン、2,2-ビス(3,4-エポキシシクロヘキサン-1-イル)プロパン、1,2-ビス(3,4-エポキシシクロヘキサン-1-イル)エタン、及び式(b-1)~(b-10)で表される化合物から選択される少なくとも1種の化合物である、[7]~[9]の何れか1つに記載の硬化性組成物。
[15] 前記カチオン硬化性化合物(好ましくはエポキシ化合物、より好ましくは脂環式エポキシ化合物、特に好ましくは脂環エポキシ基含有化合物、最も好ましくは式(b)で表される化合物)の含有量が、硬化性組成物に含まれる硬化性化合物全量の0.1~99.9重量%(好ましくは5~99重量%、より好ましくは10~98重量%、特に好ましくは10~70重量%、最も好ましくは10~40重量%)である、[7]~[14]の何れか1つに記載の硬化性組成物。
[16] 1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物と前記カチオン硬化性化合物と前記ラジカル硬化性化合物の合計含有量が、硬化性組成物に含まれる硬化性化合物全量の60重量%以上(好ましくは70重量%以上、特に好ましくは80重量%以上、最も好ましくは90重量%以上、とりわけ好ましくは95重量%以上)である、[7]~[15]の何れか1つに記載の硬化性組成物。
[17] 硬化性化合物と共に、重合開始剤、硬化剤、及び硬化促進剤から選択される1種又は2種以上を含有する、[1]~[16]の何れか1つに記載の硬化性組成物。
[18] 硬化性化合物、重合開始剤、硬化剤、及び硬化促進剤以外の成分の含有量が硬化性組成物全量の0.05~10重量%(好ましくは0.1~5重量%)である、[1]~[17]の何れか1つに記載の硬化性組成物。
[19] 炭素繊維用サイジング剤である、[1]~[18]の何れか1つに記載の硬化性組成物。
[20] 炭素繊維強化樹脂用マトリックス樹脂である、[1]~[18]の何れか1つに記載の硬化性組成物。
[21] [1]~[18]の何れか1つに記載の硬化性組成物を炭素繊維に塗布し、その後、塗布された前記硬化性組成物を硬化させることにより炭素繊維強化樹脂を得る、炭素繊維強化樹脂の製造方法。
[22] [1]~[18]の何れか1つに記載の硬化性組成物の硬化物によって炭素繊維の少なくとも一部が集束された構造を有する炭素繊維強化樹脂。
That is, the present invention relates to the following.
[1] A curable composition containing a curable compound, wherein the curable compound contains a compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule as the curable compound. A curable composition containing 0.1 to 99.9% by weight of the total amount of the functional compound.
[2] The curable composition according to [1], which is a light or thermosetting composition.
[3] A compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is a compound containing one alicyclic epoxy group and one (meth) acryloyloxy group in one molecule. ] Or the curable composition as described in [2].
[4] A compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is represented by formula (a) (wherein ring Z represents an alicyclic ring constituting an alicyclic epoxy group, and X represents a single bond. Or R 1 represents a hydrogen atom or a methyl group, and the curable composition according to [1] or [2].
[5] Ring Z in formula (a) contains 3 to 20 membered cycloalkane ring, 3 to 20 membered cycloalkene ring, or bridged ring (preferably 2 to 4 3 to 10 membered rings) The curable composition according to [4], which is a bridge ring).
[6] The curable composition according to [1] or [2], wherein the compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is a compound represented by the formula (a-1). object.
[7] The curable compound further contains a cationic curable compound (excluding a compound containing a radical curable group) and / or a radical curable compound (excluding a compound containing a cation curable group), [1] The curable composition according to any one of [6].
[8] The total content of the cationic curable compound and the radical curable compound is 0.1 to 99.9% by weight of the total amount of the curable compound contained in the curable composition (preferably 5 to 99% by weight, The curable composition according to [7], more preferably 10 to 98% by weight, particularly preferably 10 to 70% by weight, and most preferably 10 to 40% by weight.
[9] Weight ratio of the content of the compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule and the total content of the cationic curable compound and the radical curable compound (the former / the latter) The curable composition according to [7] or [8], in which is 95/5 to 60/40 (preferably 95/5 to 70/30, particularly preferably 90/10 to 75/25).
[10] The curable composition according to any one of [7] to [9], wherein the cationic curable compound is an epoxy compound.
[11] The cationically curable compound is a compound containing (i) an alicyclic epoxy group (= a group composed of two adjacent carbon atoms and oxygen atoms constituting the alicyclic ring, preferably a cyclohexene oxide group), (ii) [7]-a compound in which an epoxy group is directly bonded to the alicyclic ring with a single bond, and (iii) at least one alicyclic epoxy compound selected from a hydrogenated aromatic glycidyl ether type epoxy compound. [9] The curable composition according to any one of [9].
[12] The curable composition according to any one of [7] to [9], wherein the cationic curable compound is an alicyclic epoxy group-containing compound.
[13] The curable composition according to any one of [7] to [9], wherein the cationic curable compound is a compound represented by the formula (b).
[14] The cationically curable compound is (3,4,3 ′, 4′-diepoxy) bicyclohexyl, bis (3,4-epoxycyclohexylmethyl) ether, 1,2-epoxy-1,2-bis (3 , 4-epoxycyclohexane-1-yl) ethane, 2,2-bis (3,4-epoxycyclohexane-1-yl) propane, 1,2-bis (3,4-epoxycyclohexane-1-yl) ethane, And the curable composition according to any one of [7] to [9], which is at least one compound selected from the compounds represented by formulas (b-1) to (b-10):
[15] The content of the cationic curable compound (preferably an epoxy compound, more preferably an alicyclic epoxy compound, particularly preferably an alicyclic epoxy group-containing compound, most preferably a compound represented by the formula (b)). 0.1 to 99.9% by weight of the total amount of the curable compound contained in the curable composition (preferably 5 to 99% by weight, more preferably 10 to 98% by weight, particularly preferably 10 to 70% by weight, most The curable composition according to any one of [7] to [14], which is preferably 10 to 40% by weight).
[16] The total amount of the curable compound contained in the curable composition is the total content of the compound having an alicyclic epoxy group and (meth) acryloyloxy group in one molecule, the cationic curable compound, and the radical curable compound. Any one of [7] to [15], which is 60% by weight or more (preferably 70% by weight or more, particularly preferably 80% by weight or more, most preferably 90% by weight or more, particularly preferably 95% by weight or more). The curable composition according to one.
[17] The curability according to any one of [1] to [16], which contains one or more selected from a polymerization initiator, a curing agent, and a curing accelerator together with a curable compound. Composition.
[18] The content of components other than the curable compound, the polymerization initiator, the curing agent, and the curing accelerator is 0.05 to 10% by weight (preferably 0.1 to 5% by weight) of the total amount of the curable composition. The curable composition according to any one of [1] to [17].
[19] The curable composition according to any one of [1] to [18], which is a sizing agent for carbon fibers.
[20] The curable composition according to any one of [1] to [18], which is a matrix resin for carbon fiber reinforced resin.
[21] A carbon fiber reinforced resin is obtained by applying the curable composition according to any one of [1] to [18] to carbon fiber and then curing the applied curable composition. The manufacturing method of carbon fiber reinforced resin.
[22] A carbon fiber reinforced resin having a structure in which at least a part of carbon fibers is bundled with a cured product of the curable composition according to any one of [1] to [18].
 本発明の硬化性組成物は、硬化性化合物として、1分子中にラジカル硬化性基としての(メタ)アクリロイルオキシ基とカチオン硬化性基としての脂環エポキシ基とを有する化合物を特定の範囲で含有するため硬化性に特に優れ、光照射又は加熱処理を施すことにより速やかに硬化して、強靱性、耐擦傷性に優れた硬化物を形成することができる。そのため、本発明の硬化性組成物は、塗料、インク(例えば、3Dプリンター用インク)、接着剤、封止剤(例えば、光半導体用封止剤)、LSIや多層プリント配線板に用いられる層間絶縁膜形成材、タッチパネル用粘着シート形成材、プリプレグ形成材、サイジング剤、炭素繊維強化樹脂用マトリックス樹脂等として好適に使用することができる。例えば、本発明の硬化性組成物を炭素繊維用サイジング剤や炭素繊維強化樹脂用マトリックス樹脂として使用した場合、炭素繊維に優れた強靱性及び耐擦傷性を効率よく付与することができる。 The curable composition of the present invention includes, as a curable compound, a compound having a (meth) acryloyloxy group as a radical curable group and an alicyclic epoxy group as a cationic curable group in one molecule in a specific range. Since it contains, it is excellent in sclerosis | hardenability, and it hardens | cures rapidly by performing light irradiation or heat processing, and can form hardened | cured material excellent in toughness and scratch resistance. Therefore, the curable composition of the present invention is used for paints, inks (for example, 3D printer ink), adhesives, sealants (for example, sealants for optical semiconductors), interlayers used for LSIs and multilayer printed wiring boards. It can be suitably used as an insulating film forming material, an adhesive sheet forming material for touch panels, a prepreg forming material, a sizing agent, a matrix resin for carbon fiber reinforced resin, and the like. For example, when the curable composition of the present invention is used as a carbon fiber sizing agent or a carbon fiber reinforced resin matrix resin, excellent toughness and scratch resistance can be efficiently imparted to the carbon fiber.
 [硬化性組成物]
 本発明の硬化性組成物は、硬化性化合物を含む硬化性組成物であって、前記硬化性化合物として、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物(以後、「成分(A)」や「脂環エポキシ基含有アクリレート」と称する場合がある)の少なくとも1種を、硬化性組成物に含まれる硬化性化合物全量の0.1~99.9重量%含有する。
 本発明の硬化性組成物は、硬化性化合物として、前記成分(A)以外にも、例えば後述の成分(B)、成分(C)を含有していても良い。また、硬化性化合物と共に成分(D)として、重合開始剤、硬化剤、及び硬化促進剤から選択される1種又は2種以上を含有していても良い。
[Curable composition]
The curable composition of the present invention is a curable composition containing a curable compound, and the curable compound includes a compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule (hereinafter, “ At least one of the component (A) ”and the“ alicyclic epoxy group-containing acrylate ”may be contained in an amount of 0.1 to 99.9% by weight of the total amount of the curable compound contained in the curable composition.
The curable composition of this invention may contain the below-mentioned component (B) and component (C) other than the said component (A) as a sclerosing | hardenable compound, for example. Moreover, you may contain 1 type, or 2 or more types selected from a polymerization initiator, a hardening | curing agent, and a hardening accelerator as a component (D) with a sclerosing | hardenable compound.
 [成分(A):脂環エポキシ基含有アクリレート]
 脂環エポキシ基含有アクリレートは、1分子中にカチオン硬化性基としての脂環エポキシ基と、ラジカル硬化性基としての(メタ)アクリロイルオキシ基を有する化合物である。尚、本明細書における「脂環エポキシ基」は、「脂環を構成する隣り合う2つの炭素原子と酸素原子とで構成される基」である。また、本明細書における「(メタ)アクリロイルオキシ基」は、アクリロイルオキシ基とメタクリロイルオキシ基のことである。
[Component (A): Alicyclic epoxy group-containing acrylate]
An alicyclic epoxy group-containing acrylate is a compound having an alicyclic epoxy group as a cationic curable group and a (meth) acryloyloxy group as a radical curable group in one molecule. In the present specification, the “alicyclic epoxy group” is “a group composed of two adjacent carbon atoms and oxygen atoms constituting the alicyclic ring”. In addition, “(meth) acryloyloxy group” in the present specification refers to an acryloyloxy group and a methacryloyloxy group.
 本発明の脂環エポキシ基含有アクリレートとしては、特に、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を1個ずつ含有する化合物が好ましく、例えば下記式(a)で表される脂環エポキシ基含有(メタ)アクリレートが好ましい。
Figure JPOXMLDOC01-appb-C000003
The alicyclic epoxy group-containing acrylate of the present invention is particularly preferably a compound containing one alicyclic epoxy group and one (meth) acryloyloxy group in one molecule. For example, an alicyclic epoxy group-containing acrylate represented by the following formula (a) A cyclic epoxy group-containing (meth) acrylate is preferred.
Figure JPOXMLDOC01-appb-C000003
 上記式中、環Zは脂環エポキシ基を構成する脂環を示し、Xは単結合又は連結基を示す。R1は水素原子又はメチル基を示す。 In said formula, the ring Z shows the alicyclic ring which comprises an alicyclic epoxy group, X shows a single bond or a coupling group. R 1 represents a hydrogen atom or a methyl group.
 前記脂環としては、例えば、シクロプロパン、シクロブタン、シクロペンタン、シクロヘキサン、シクロヘプタン、シクロオクタン等の3~20員(好ましくは3~15員、特に好ましくは5~8員)程度のシクロアルカン環;シクロペンテン、シクロへキセン等の3~20員(好ましくは3~15員、特に好ましくは5~8員)程度のシクロアルケン環;パーヒドロナフタレン、ノルボルナン、アダマンタン、トリシクロ[5.2.1.02,6]デカン、テトラシクロ[4.4.0.12,5.17,10]ドデカン等の橋かけ環等を挙げることができる。また、前記脂環には芳香族性又は非芳香属性の複素環が縮合していてもよい。 Examples of the alicyclic ring include cycloalkane rings of about 3 to 20 members (preferably 3 to 15 members, particularly preferably 5 to 8 members) such as cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, and cyclooctane. A cycloalkene ring of about 3 to 20 members (preferably 3 to 15 members, particularly preferably 5 to 8 members) such as cyclopentene and cyclohexene; perhydronaphthalene, norbornane, adamantane, tricyclo [5.2.1. 0 2,6 ] decane, tetracyclo [4.4.0.1 2,5 . 1, 7, 10 ] Dodecane and other bridging rings. The alicyclic ring may be condensed with an aromatic or non-aromatic heterocyclic ring.
 前記脂環は、種々の置換基を有していてもよい。置換基としては、例えば、ハロゲン原子、オキソ基、ヒドロキシル基、置換オキシ基(例えば、C1-4アルコキシ基、C6-10アリールオキシ基、C7-16アラルキルオキシ基、C1-4アシルオキシ基等)、カルボキシル基、置換オキシカルボニル基(例えば、C1-4アルコキシカルボニル基、C6-10アリールオキシカルボニル基、C7-16アラルキルオキシカルボニル基等)、置換又は無置換カルバモイル基(例えば、カルバモイル、メチルカルバモイル等のC1-4アルキル置換カルバモイル、フェニルカルバモイル基等のC6-10アリール置換カルバモイル基)、シアノ基、ニトロ基、置換又は無置換アミノ基(例えば、メチルアミノ、ジメチルアミノ、エチルアミノ、ジエチルアミノ基等のモノ又はジC1-4アルキルアミノ基;1-ピロリジニル、ピペリジノ、モルホリノ基等の5~8員の環状アミノ基;アセチルアミノ、プロピオニルアミノ、ベンゾイルアミノ基等のC1-10アシルアミノ基;ベンゼンスルホニルアミノ、p-トルエンスルホニルアミノ基等のスルホニルアミノ基)、スルホ基、複素環式基、アルキル基(例えば、メチル基、エチル基等のC1-4アルキル基等)、アルケニル基(例えば、ビニル基、アリル基、1-ブテニル基等のC2-4アルケニル基)、アルキニル基(例えば、エチニル基、プロピニル基等のC2-4アルキニル基等)、C3-8シクロアルキル基、アリール基(例えば、フェニル基、ナフチル基等のC6-10アリール基)等を挙げることができる。 The alicyclic ring may have various substituents. Examples of the substituent include a halogen atom, an oxo group, a hydroxyl group, a substituted oxy group (for example, a C 1-4 alkoxy group, a C 6-10 aryloxy group, a C 7-16 aralkyloxy group, a C 1-4 acyloxy group). Group), carboxyl group, substituted oxycarbonyl group (eg C 1-4 alkoxycarbonyl group, C 6-10 aryloxycarbonyl group, C 7-16 aralkyloxycarbonyl group etc.), substituted or unsubstituted carbamoyl group (eg C 1-4 alkyl substituted carbamoyl such as carbamoyl, methyl carbamoyl, C 6-10 aryl substituted carbamoyl group such as phenyl carbamoyl group), cyano group, nitro group, substituted or unsubstituted amino group (eg, methylamino, dimethylamino) , ethylamino, mono- or di-C 1-4 alkylamino group such as a diethylamino group; 1-pyrrolidinyl, Piperi Bruno, cyclic amino group of 5-8 membered, such as a morpholino group; acetylamino, propionylamino, C 1-10 acylamino group such as benzoylamino group; benzenesulfonylamino, p- toluenesulfonyl sulfonylamino group such as an amino group), Sulfo group, heterocyclic group, alkyl group (eg, C 1-4 alkyl group such as methyl group, ethyl group, etc.), alkenyl group (eg, C 2-4 such as vinyl group, allyl group, 1-butenyl group, etc.) Alkenyl group), alkynyl group (for example, C 2-4 alkynyl group such as ethynyl group, propynyl group, etc.), C 3-8 cycloalkyl group, aryl group (for example, C 6-10 aryl such as phenyl group, naphthyl group, etc.) Group) and the like.
 前記Xにおける連結基は1個以上の原子を有する2価の基であり、例えば、2価の炭化水素基、カルボニル基(-CO-)、エーテル結合(-O-)、チオエーテル結合(-S-)、エステル結合(-COO-)、アミド結合(-CONH-)、カーボネート結合(-OCOO-)、及びこれらから選択される2個以上が結合した基等を挙げることができる。 The linking group in X is a divalent group having one or more atoms. For example, a divalent hydrocarbon group, a carbonyl group (—CO—), an ether bond (—O—), a thioether bond (—S -), An ester bond (-COO-), an amide bond (-CONH-), a carbonate bond (-OCOO-), and a group in which two or more selected from these are bonded.
 前記2価の炭化水素基としては、例えば、メチレン基、メチルメチレン基、ジメチルメチレン基、エチレン基、プロピレン基、トリメチレン基等の炭素数1~20(好ましくは1~10、特に好ましくは1~3)程度のアルキレン基;ビニレン基、プロペニレン基、1-ブテニレン基等の炭素数2~20(好ましくは2~10、特に好ましくは2~4)程度のアルケニレン基;エチニレン基、プロピニレン基等の炭素数2~20(好ましくは2~10、特に好ましくは2~3)程度のアルキニレン基;1,2-シクロペンチレン基、1,3-シクロペンチレン基、シクロペンチリデン基、1,2-シクロヘキシレン基、1,3-シクロヘキシレン基、1,4-クロヘキシレン基、シクロヘキシリデン基等の炭素数3~20(好ましくは3~10、特に好ましくは3~6)程度のシクロアルキレン基(シクロアルキリデン基を含む)等を挙げることができる。 Examples of the divalent hydrocarbon group include 1 to 20 carbon atoms such as a methylene group, a methylmethylene group, a dimethylmethylene group, an ethylene group, a propylene group, and a trimethylene group (preferably 1 to 10, particularly preferably 1 to An alkylene group of about 3); an alkenylene group of about 2 to 20 carbon atoms (preferably 2 to 10, particularly preferably 2 to 4) such as a vinylene group, a propenylene group, or a 1-butenylene group; an ethynylene group, a propynylene group, etc. An alkynylene group having about 2 to 20 carbon atoms (preferably 2 to 10, particularly preferably 2 to 3); 1,2-cyclopentylene group, 1,3-cyclopentylene group, cyclopentylidene group, 1,2 -C3-20 (preferably 3-3) such as cyclohexylene group, 1,3-cyclohexylene group, 1,4-cyclohexylene group, cyclohexylidene group, etc. 0, particularly preferable examples thereof include such as 3-6) about a cycloalkylene group (including cycloalkylidene group).
 本発明の脂環エポキシ基含有アクリレートとしては、なかでも、下記式(a-1)で表される化合物が、感作性などの安全性の観点で好ましい。尚、下記式中のX、R1は前記に同じ。本発明においては、例えば、商品名「E-DCPA」(下記式中のXが単結合である化合物;(株)ダイセル製)等の市販品を好適に使用することができる。
Figure JPOXMLDOC01-appb-C000004
As the alicyclic epoxy group-containing acrylate of the present invention, among them, a compound represented by the following formula (a-1) is preferable from the viewpoint of safety such as sensitization. In the following formula, X and R 1 are the same as described above. In the present invention, for example, a commercially available product such as a trade name “E-DCPA” (a compound in which X in the following formula is a single bond; manufactured by Daicel Corporation) can be suitably used.
Figure JPOXMLDOC01-appb-C000004
 [成分(B);カチオン硬化性化合物]
 本発明における成分(B)は、1分子内に1個以上のカチオン硬化性基を有する化合物である(ラジカル硬化性基を含む化合物は除く)。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。カチオン硬化性基としては、例えば、エポキシ基、オキセタン基、ビニルエーテル基等を挙げることができる。本発明においては、なかでも、カチオン硬化性基としてエポキシ基を含有する化合物、すなわちエポキシ化合物が、カチオン硬化性と得られる硬化物の物性のバランスの点で好ましい。
[Component (B); Cation curable compound]
Component (B) in the present invention is a compound having one or more cationic curable groups in one molecule (excluding compounds containing radical curable groups). These can be used alone or in combination of two or more. Examples of the cationic curable group include an epoxy group, an oxetane group, and a vinyl ether group. In the present invention, among them, a compound containing an epoxy group as a cationic curable group, that is, an epoxy compound is preferable from the viewpoint of the balance between the cationic curable property and the physical properties of the obtained cured product.
 エポキシ化合物は、1分子内に1個以上のエポキシ基(オキシラン環)を有する化合物であり、例えば、脂環式エポキシ化合物;芳香族エポキシ化合物(例えば、ビスフェノールA型エポキシ化合物、ビスフェノールF型エポキシ化合物等の芳香族グリシジルエーテル系エポキシ化合物);脂肪族エポキシ化合物;グリシジルエステル系エポキシ化合物;グリシジルアミン系エポキシ化合物;エポキシ変性シロキサン化合物等が含まれる。本発明においては脂環式エポキシ化合物を使用することが、カチオン硬化性が特に優れる点で好ましい。 The epoxy compound is a compound having one or more epoxy groups (oxirane rings) in one molecule, such as an alicyclic epoxy compound; an aromatic epoxy compound (for example, bisphenol A type epoxy compound, bisphenol F type epoxy compound). Aromatic glycidyl ether epoxy compounds); aliphatic epoxy compounds; glycidyl ester epoxy compounds; glycidyl amine epoxy compounds; epoxy-modified siloxane compounds and the like. In the present invention, it is preferable to use an alicyclic epoxy compound in view of particularly excellent cationic curability.
 前記脂環式エポキシ化合物には、下記(i)~(iii)の化合物が含まれる。
(i)脂環エポキシ基を有する化合物(以後、「脂環エポキシ基含有化合物」と称する場合がある)
(ii)脂環にエポキシ基が直接単結合で結合している化合物
(iii)水素化芳香族グリシジルエーテル系エポキシ化合物
The alicyclic epoxy compound includes the following compounds (i) to (iii).
(I) Compound having an alicyclic epoxy group (hereinafter sometimes referred to as “alicyclic epoxy group-containing compound”)
(Ii) a compound in which an epoxy group is directly bonded to the alicyclic ring by a single bond (iii) a hydrogenated aromatic glycidyl ether-based epoxy compound
 本発明においては、とりわけ上記(i)の化合物、すなわち脂環エポキシ基含有化合物が好ましい。前記脂環エポキシ基含有化合物としては、なかでも、強靱性及び耐擦傷性に特に優れる硬化物が得られる点で、シクロヘキセンオキシド基を有する化合物が好ましく、特に、下記式(b)で表される化合物が好ましい。
Figure JPOXMLDOC01-appb-C000005
In the present invention, the above compound (i), that is, an alicyclic epoxy group-containing compound is particularly preferable. As the alicyclic epoxy group-containing compound, among them, a compound having a cyclohexene oxide group is preferable in that a cured product particularly excellent in toughness and scratch resistance is obtained, and particularly represented by the following formula (b). Compounds are preferred.
Figure JPOXMLDOC01-appb-C000005
 上記式(b)中、Yは単結合又は連結基を示す。前記連結基としては、例えば、二価の炭化水素基、炭素-炭素二重結合の一部又は全部がエポキシ化されたアルケニレン基、カルボニル基(-CO-)、エーテル結合(-O-)、エステル結合(-COO-)、カーボネート基(-O-CO-O-)、アミド基(-CONH-)、及びこれらが複数個連結した基等を挙げることができる。また、式(b)中のシクロヘキセンオキシド基は、例えばC1-5アルキル基等の置換基を有していてもよい。 In said formula (b), Y shows a single bond or a coupling group. Examples of the linking group include a divalent hydrocarbon group, an alkenylene group in which part or all of a carbon-carbon double bond is epoxidized, a carbonyl group (—CO—), an ether bond (—O—), Examples include an ester bond (—COO—), a carbonate group (—O—CO—O—), an amide group (—CONH—), and a group in which a plurality of these are linked. Further, the cyclohexene oxide group in the formula (b) may have a substituent such as a C 1-5 alkyl group.
 上記二価の炭化水素基としては、前記Xにおける二価の炭化水素基と同様の例を挙げることができる。また、前記二価の炭化水素基は種々の置換基[例えば、ハロゲン原子、オキソ基、ヒドロキシル基、カルボキシル基、置換又は無置換カルバモイル基、シアノ基、ニトロ基、置換又は無置換アミノ基、スルホ基、エポキシ基、複素環式基等]を有していてもよい。前記ヒドロキシル基やカルボキシル基は有機合成の分野で慣用の保護基で保護されていてもよい。 Examples of the divalent hydrocarbon group include the same examples as the divalent hydrocarbon group in X. The divalent hydrocarbon group may be any of various substituents [eg, halogen atom, oxo group, hydroxyl group, carboxyl group, substituted or unsubstituted carbamoyl group, cyano group, nitro group, substituted or unsubstituted amino group, sulfo group. Group, epoxy group, heterocyclic group, etc.]. The hydroxyl group and carboxyl group may be protected with a protective group commonly used in the field of organic synthesis.
 上記炭素-炭素二重結合の一部又は全部がエポキシ化されたアルケニレン基(「エポキシ化アルケニレン基」と称する場合がある)におけるアルケニレン基としては、例えば、ビニレン基、プロペニレン基、1-ブテニレン基、2-ブテニレン基、ブタジエニレン基、ペンテニレン基、ヘキセニレン基、ヘプテニレン基、オクテニレン基等の炭素数2~8の直鎖又は分岐鎖状のアルケニレン基等が挙げられる。特に、上記エポキシ化アルケニレン基としては、炭素-炭素二重結合の全部がエポキシ化されたアルケニレン基が好ましく、より好ましくは炭素-炭素二重結合の全部がエポキシ化された炭素数2~4のアルケニレン基である。 Examples of the alkenylene group in the alkenylene group in which part or all of the carbon-carbon double bond is epoxidized (sometimes referred to as “epoxidized alkenylene group”) include, for example, vinylene group, propenylene group, 1-butenylene group And straight-chain or branched alkenylene groups having 2 to 8 carbon atoms such as 2-butenylene group, butadienylene group, pentenylene group, hexenylene group, heptenylene group, octenylene group and the like. In particular, the epoxidized alkenylene group is preferably an alkenylene group in which all of the carbon-carbon double bonds are epoxidized, more preferably 2 to 4 carbon atoms in which all of the carbon-carbon double bonds are epoxidized. Alkenylene group.
 上記脂環エポキシ基含有化合物の代表的な例としては、例えば、(3,4,3’,4’-ジエポキシ)ビシクロヘキシル、ビス(3,4-エポキシシクロヘキシルメチル)エーテル、1,2-エポキシ-1,2-ビス(3,4-エポキシシクロヘキサン-1-イル)エタン、2,2-ビス(3,4-エポキシシクロヘキサン-1-イル)プロパン、1,2-ビス(3,4-エポキシシクロヘキサン-1-イル)エタン、及び下記式(b-1)~(b-10)で表される化合物等を挙げることができる。なお、下記式(b-5)、(b-7)中のn1、n2は、それぞれ1~30の整数を表す。下記式(b-5)中のLは炭素数1~8のアルキレン基であり、例えば、メチレン基、エチレン基、プロピレン基、イソプロピレン基、ブチレン基、イソブチレン基、s-ブチレン基、ペンチレン基、ヘキシレン基、ヘプチレン基、オクチレン基等の直鎖又は分岐鎖状のアルキレン基が挙げられる。これらの中でも、メチレン基、エチレン基、プロピレン基、イソプロピレン基等の炭素数1~3の直鎖又は分岐鎖状のアルキレン基が好ましい。下記式(b-9)、(b-10)中のn3~n8は、それぞれ1~30の整数を示す。 Representative examples of the alicyclic epoxy group-containing compound include, for example, (3,4,3 ′, 4′-diepoxy) bicyclohexyl, bis (3,4-epoxycyclohexylmethyl) ether, 1,2-epoxy. -1,2-bis (3,4-epoxycyclohexane-1-yl) ethane, 2,2-bis (3,4-epoxycyclohexane-1-yl) propane, 1,2-bis (3,4-epoxy) And cyclohexane-1-yl) ethane and compounds represented by the following formulas (b-1) to (b-10). In the following formulas (b-5) and (b-7), n 1 and n 2 each represents an integer of 1 to 30. L in the following formula (b-5) is an alkylene group having 1 to 8 carbon atoms, for example, methylene group, ethylene group, propylene group, isopropylene group, butylene group, isobutylene group, s-butylene group, pentylene group. , A linear or branched alkylene group such as a hexylene group, a heptylene group, and an octylene group. Among these, linear or branched alkylene groups having 1 to 3 carbon atoms such as a methylene group, an ethylene group, a propylene group, and an isopropylene group are preferable. N 3 to n 8 in the following formulas (b-9) and (b-10) each represents an integer of 1 to 30.
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
 上述の(ii)脂環にエポキシ基が直接単結合で結合している化合物としては、例えば、下記式(b2)で表される化合物などが挙げられる。
Figure JPOXMLDOC01-appb-C000008
Examples of the compound (ii) in which the epoxy group is directly bonded to the alicyclic ring with a single bond include a compound represented by the following formula (b2).
Figure JPOXMLDOC01-appb-C000008
 式(b2)中、R”はp価のアルコールの構造式からp個のOH基を除いた基であり、p、nはそれぞれ自然数を表す。p価のアルコール[R”-(OH)p]としては、例えば、2,2-ビス(ヒドロキシメチル)-1-ブタノール等の多価アルコールなど(炭素数1~15のアルコール等)が挙げられる。pは1~6が好ましく、nは1~30が好ましい。pが2以上の場合、それぞれの[ ]内(外側の括弧内)の基におけるnは同一であってもよいし、異なっていてもよい。上記化合物としては、具体的には、2,2-ビス(ヒドロキシメチル)-1-ブタノールの1,2-エポキシ-4-(2-オキシラニル)シクロヘキサン付加物、商品名「EHPE3150」((株)ダイセル製)などが挙げられる。 In the formula (b2), R ″ is a group obtained by removing p OH groups from the structural formula of the p-valent alcohol, and p and n each represent a natural number. The p-valent alcohol [R ″-(OH) p ] Includes, for example, polyhydric alcohols such as 2,2-bis (hydroxymethyl) -1-butanol (alcohols having 1 to 15 carbon atoms, etc.). p is preferably 1 to 6, and n is preferably 1 to 30. In the case where p is 2 or more, ns in the respective groups within [] (inside the outer parentheses) may be the same or different. Specific examples of the above compound include 1,2-epoxy-4- (2-oxiranyl) cyclohexane adduct of 2,2-bis (hydroxymethyl) -1-butanol, trade name “EHPE3150” (Co., Ltd.). Daicel) and the like.
 上記(iii)水素化芳香族グリシジルエーテル系エポキシ化合物としては、例えば、2,2-ビス[4-(2,3-エポキシプロポキシ)シクロへキシル]プロパン、2,2-ビス[3,5-ジメチル-4-(2,3-エポキシプロポキシ)シクロへキシル]プロパンなどのビスフェノールA型エポキシ化合物を水素化した化合物(核水添ビスフェノールA型エポキシ化合物);ビス[o,o-(2,3-エポキシプロポキシ)シクロへキシル]メタン、ビス[o,p-(2,3-エポキシプロポキシ)シクロへキシル]メタン、ビス[p,p-(2,3-エポキシプロポキシ)シクロへキシル]メタン、ビス[3,5-ジメチル-4-(2,3-エポキシプロポキシ)シクロへキシル]メタンなどのビスフェノールF型エポキシ化合物を水素化した化合物(核水添ビスフェノールF型エポキシ化合物);水添ビフェノール型エポキシ化合物;水添フェノールノボラック型エポキシ化合物;水添クレゾールノボラック型エポキシ化合物;水添ビスフェノールAのクレゾールノボラック型エポキシ化合物;水添ナフタレン型エポキシ化合物;トリスフェノールメタン型エポキシ化合物を水素化した化合物などが挙げられる。 Examples of the (iii) hydrogenated aromatic glycidyl ether-based epoxy compound include 2,2-bis [4- (2,3-epoxypropoxy) cyclohexyl] propane, 2,2-bis [3,5- A compound obtained by hydrogenating a bisphenol A type epoxy compound such as dimethyl-4- (2,3-epoxypropoxy) cyclohexyl] propane (nuclear hydrogenated bisphenol A type epoxy compound); bis [o, o- (2,3 -Epoxypropoxy) cyclohexyl] methane, bis [o, p- (2,3-epoxypropoxy) cyclohexyl] methane, bis [p, p- (2,3-epoxypropoxy) cyclohexyl] methane, Bisphenol F type epoxy compounds such as bis [3,5-dimethyl-4- (2,3-epoxypropoxy) cyclohexyl] methane Compound (nuclear hydrogenated bisphenol F type epoxy compound); hydrogenated biphenol type epoxy compound; hydrogenated phenol novolak type epoxy compound; hydrogenated cresol novolak type epoxy compound; cresol novolak type epoxy compound of hydrogenated bisphenol A; Naphthalene type epoxy compounds; compounds obtained by hydrogenating trisphenolmethane type epoxy compounds, and the like.
 [成分(C):ラジカル硬化性化合物]
 本発明における成分(C)は、分子内に1個以上のラジカル硬化性基(例えば、(メタ)アクリロイルオキシ基、ビニル基、ビニルエーテル基等)を有する化合物である(カチオン硬化性基を含む化合物は除く)。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。
[Component (C): Radical curable compound]
Component (C) in the present invention is a compound having one or more radical curable groups (for example, (meth) acryloyloxy group, vinyl group, vinyl ether group, etc.) in the molecule (compound containing a cationic curable group) Except). These can be used alone or in combination of two or more.
 ラジカル硬化性化合物としては、例えば、メチル(メタ)アクリレート、エチル(メタ)アクリレート、プロピル(メタ)アクリレート、ブチル(メタ)アクリレート、ペンチル(メタ)アクリレート、ヘキシル(メタ)アクリレートなどの(メタ)アクリル酸アルキルエステル[例えば、(メタ)アクリル酸C1-10アルキルエステル等];ベンジル(メタ)アクリレート、シクロヘキシル(メタ)アクリレート、シクロペンチル(メタ)アクリレート、アダマンチル(メタ)アクリレート、シクロペンテニル(メタ)アクリレート、イソボロニル(メタ)アクリレート、ジシクロペンタニル(メタ)アクリレート、ジシクロペンテニル(メタ)アクリレート、2-(ジシクロペンテニルオキシ)エチル(メタ)アクリレート、2-(ジシクロペンタニルオキシ)エチル(メタ)アクリレートなどの分子内に環状構造(脂肪族環状構造又は芳香族環状構造)を有する(メタ)アクリル酸エステル;スチレン、ビニルトルエン、α-メチルスチレン、ビニルナフタレンなどのスチレン系化合物;メチルビニルエーテル、ブチルビニルエーテル、フェニルビニルエーテル等のビニルエーテル化合物、及びこれらの誘導体(例えば、水酸基、カルボキシル基、第4級アンモニウム基、アミノ基、複素環式基等の置換基が結合した化合物)等を挙げることができる。 Examples of the radical curable compound include (meth) acryl such as methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, butyl (meth) acrylate, pentyl (meth) acrylate, and hexyl (meth) acrylate. Acid alkyl ester [eg (meth) acrylic acid C 1-10 alkyl ester, etc.]; benzyl (meth) acrylate, cyclohexyl (meth) acrylate, cyclopentyl (meth) acrylate, adamantyl (meth) acrylate, cyclopentenyl (meth) acrylate , Isobornyl (meth) acrylate, dicyclopentanyl (meth) acrylate, dicyclopentenyl (meth) acrylate, 2- (dicyclopentenyloxy) ethyl (meth) acrylate, 2- (disicyl) (Meth) acrylic acid ester having a cyclic structure (aliphatic cyclic structure or aromatic cyclic structure) in the molecule such as pentanyloxy) ethyl (meth) acrylate; styrene, vinyltoluene, α-methylstyrene, vinylnaphthalene, etc. Styrenic compounds; vinyl ether compounds such as methyl vinyl ether, butyl vinyl ether, and phenyl vinyl ether, and derivatives thereof (for example, compounds in which substituents such as a hydroxyl group, a carboxyl group, a quaternary ammonium group, an amino group, and a heterocyclic group are bonded. And the like.
 [成分(D);重合開始剤、硬化剤、硬化促進剤]
 本発明の硬化性組成物は、上述の硬化性化合物と共に、重合開始剤、硬化剤、及び硬化促進剤から選択される1種又は2種以上を含有することが好ましく、特に、重合開始剤(好ましくは、ラジカル重合開始剤とカチオン重合開始剤)、若しくは、硬化剤と硬化促進剤を含有することが好ましい。
[Component (D); polymerization initiator, curing agent, curing accelerator]
The curable composition of the present invention preferably contains one or more selected from a polymerization initiator, a curing agent, and a curing accelerator together with the above-described curable compound. Preferably, it contains a radical polymerization initiator and a cationic polymerization initiator) or a curing agent and a curing accelerator.
 重合開始剤には、光ラジカル重合開始剤、熱ラジカル重合開始剤、光カチオン重合開始剤、及び熱カチオン重合開始剤が含まれる。 The polymerization initiator includes a radical photopolymerization initiator, a thermal radical polymerization initiator, a cationic photopolymerization initiator, and a thermal cationic polymerization initiator.
 (光ラジカル重合開始剤)
 上記光ラジカル重合開始剤としては、例えば、ベンゾフェノン、アセトフェノンベンジル、ベンジルジメチルケトン、ベンゾイン、ベンゾインメチルエーテル、ベンゾインエチルエーテル、ベンゾインイソプロピルエーテル、ジメトキシアセトフェノン、ジメトキシフェニルアセトフェノン、ジエトキシアセトフェノン、ジフェニルジサルファイト、オルトベンゾイル安息香酸メチル、4-ジメチルアミノ安息香酸エチル(日本化薬(株)製、商品名「カヤキュアEPA」等)、2,4-ジエチルチオキサンソン(日本化薬(株)製、商品名「カヤキュアDETX」等)、2-メチル-1-[4-(メチル)フェニル]-2-モルホリノプロパノン-1(BASF社製、商品名「イルガキュア907」等)、1-ヒドロキシシクロヘキシルフェニルケトン(BASF社製、商品名「イルガキュア184」等)、2-ジメチルアミノ-2-(4-モルホリノ)ベンゾイル-1-フェニルプロパン等の2-アミノ-2-ベンゾイル-1-フェニルアルカン化合物、テトラ(t-ブチルパーオキシカルボニル)ベンゾフェノン、ベンジル、2-ヒドロキシ-2-メチル-1-フェニル-プロパン-1-オン、4,4’-ビス(ジエチルアミノ)ベンゾフェノン等のアミノベンゼン誘導体、2,2’-ビス(2-クロロフェニル)-4,5,4’,5’-テトラフェニル-1,2’-ビイミダゾ-ル(保土谷化学(株)製、商品名「B-CIM」等)等のイミダゾール化合物、2,6-ビス(トリクロロメチル)-4-(4-メトキシナフタレン-1-イル)-1,3,5-トリアジン等のハロメチル化トリアジン化合物、2-トリクロロメチル-5-(2-ベンゾフラン2-イル-エテニル)-1,3,4-オキサジアゾール等のハロメチルオキサジアゾール化合物等を挙げることができる。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。
(Photo radical polymerization initiator)
Examples of the photo radical polymerization initiator include benzophenone, acetophenone benzyl, benzyl dimethyl ketone, benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, dimethoxyacetophenone, dimethoxyphenylacetophenone, diethoxyacetophenone, diphenyl disulfite, Orthobenzoyl methyl benzoate, ethyl 4-dimethylaminobenzoate (Nippon Kayaku Co., Ltd., trade name “Kayacure EPA”, etc.), 2,4-diethylthioxanthone (Nippon Kayaku Co., Ltd., trade name) “Kayacure DETX” etc.), 2-methyl-1- [4- (methyl) phenyl] -2-morpholinopropanone-1 (manufactured by BASF, trade name “Irgacure 907” etc.), 1-hydroxycyclohexyl 2-amino-2-benzoyl-1-phenylalkane compounds such as nilketone (manufactured by BASF, trade name “Irgacure 184”, etc.), 2-dimethylamino-2- (4-morpholino) benzoyl-1-phenylpropane, tetra Aminobenzene derivatives such as (t-butylperoxycarbonyl) benzophenone, benzyl, 2-hydroxy-2-methyl-1-phenyl-propan-1-one, 4,4′-bis (diethylamino) benzophenone, 2,2 ′ -Imidazoles such as bis (2-chlorophenyl) -4,5,4 ', 5'-tetraphenyl-1,2'-biimidazole (made by Hodogaya Chemical Co., Ltd., trade name "B-CIM", etc.) Compounds, 2,6-bis (trichloromethyl) -4- (4-methoxynaphthalen-1-yl) -1,3,5-triazine and the like And halomethyloxadiazole compounds such as 2-trichloromethyl-5- (2-benzofuran-2-yl-ethenyl) -1,3,4-oxadiazole, and the like. These can be used alone or in combination of two or more.
 (熱ラジカル重合開始剤)
 上記熱ラジカル重合開始剤としては、例えば、アゾビスイソブチロニトリル等のアゾ化合物や、ハイドロパーオキサイド、ジアルキルパーオキサイド、パーオキシエステル、ジアシルパーオキサイド、パーオキシジカーボネート、パーオキシケタール、ケトンパーオキサイド等(具体的には、ベンゾイルパーオキサイド、t-ブチルパーオキシ-2-エチルヘキサノエート、2,5-ジメチル-2,5-ジ(2-エチルヘキサノイル)パーオキシヘキサン、t-ブチルパーオキシベンゾエート、t-ブチルパーオキサイド、クメンハイドロパーオキサイド、ジクミルパーオキサイド、ジ-t-ブチルパーオキサイド、2,5-ジメチル-2,5-ジブチルパーオキシヘキサン、2,4-ジクロロベンゾイルパーオキサイド、1,4-ジ(2-t-ブチルパーオキシイソプロピル)ベンゼン、1,1-ビス(t-ブチルパーオキシ)-3,3,5-トリメチルシクロヘキサン、メチルエチルケトンパーオキサイド、1,1,3,3-テトラメチルブチルパーオキシ-2-エチルヘキサノエート等)等の有機過酸化物類を挙げることができる。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。
(Thermal radical polymerization initiator)
Examples of the thermal radical polymerization initiator include azo compounds such as azobisisobutyronitrile, hydroperoxide, dialkyl peroxide, peroxyester, diacyl peroxide, peroxydicarbonate, peroxyketal, and ketone peroxide. Oxides (specifically, benzoyl peroxide, t-butylperoxy-2-ethylhexanoate, 2,5-dimethyl-2,5-di (2-ethylhexanoyl) peroxyhexane, t-butyl Peroxybenzoate, t-butyl peroxide, cumene hydroperoxide, dicumyl peroxide, di-t-butyl peroxide, 2,5-dimethyl-2,5-dibutylperoxyhexane, 2,4-dichlorobenzoylper Oxide, 1,4-di (2- -Butylperoxyisopropyl) benzene, 1,1-bis (t-butylperoxy) -3,3,5-trimethylcyclohexane, methyl ethyl ketone peroxide, 1,1,3,3-tetramethylbutylperoxy-2- And organic peroxides such as ethylhexanoate). These can be used alone or in combination of two or more.
 (光カチオン重合開始剤)
 光カチオン重合開始剤は、光の照射によって酸を発生して、硬化性組成物に含まれるカチオン硬化性化合物の硬化反応を開始させる化合物であり、光を吸収するカチオン部と酸の発生源となるアニオン部からなる。
(Photocationic polymerization initiator)
The cationic photopolymerization initiator is a compound that generates an acid upon irradiation with light and initiates a curing reaction of the cationic curable compound contained in the curable composition, and includes a cation moiety that absorbs light and a source of acid generation. It consists of the anion part.
 光カチオン重合開始剤としては、例えば、ジアゾニウム塩系化合物、ヨードニウム塩系化合物、スルホニウム塩系化合物、ホスホニウム塩系化合物、セレニウム塩系化合物、オキソニウム塩系化合物、アンモニウム塩系化合物、臭素塩系化合物等を挙げることができるが、なかでも、スルホニウム塩系化合物を使用することが、硬化性に優れた硬化物を形成することができる点で好ましい。 Examples of the cationic photopolymerization initiator include diazonium salt compounds, iodonium salt compounds, sulfonium salt compounds, phosphonium salt compounds, selenium salt compounds, oxonium salt compounds, ammonium salt compounds, bromine salt compounds, and the like. Among them, it is preferable to use a sulfonium salt compound in that a cured product having excellent curability can be formed.
 スルホニウム塩系化合物のカチオン部としては、例えば、(4-ヒドロキシフェニル)メチルベンジルスルホニウムイオン、トリフェニルスルホニウムイオン、ジフェニル[4-(フェニルチオ)フェニル]スルホニウムイオン、4-(4-ビフェニリルチオ)フェニル-4-ビフェニリルフェニルスルホニウムイオン、トリ-p-トリルスルホニウムイオン等のアリールスルホニウムイオン(特に、トリアリールスルホニウムイオン)を挙げることができる。 Examples of the cation moiety of the sulfonium salt compound include (4-hydroxyphenyl) methylbenzylsulfonium ion, triphenylsulfonium ion, diphenyl [4- (phenylthio) phenyl] sulfonium ion, and 4- (4-biphenylylthio) phenyl. Examples thereof include arylsulfonium ions such as -4-biphenylylphenylsulfonium ion and tri-p-tolylsulfonium ion (particularly, triarylsulfonium ion).
 光カチオン重合開始剤のアニオン部としては、例えば、[(Y)sB(Phf)4-s-(式中、Yはフェニル基又はビフェニリル基を示す。Phfは水素原子の少なくとも1つが、パーフルオロアルキル基、パーフルオロアルコキシ基、及びハロゲン原子から選択される少なくとも1種で置換されたフェニル基を示す。sは0~3の整数である)、BF4 -、[(Rf)tPF6-t-(Rf:水素原子の80%以上がフッ素原子で置換されたアルキル基、t:0~5の整数)、AsF6 -、SbF6 -、SbF5OH-等を挙げることができる。 As an anion part of the photocationic polymerization initiator, for example, [(Y) s B (Phf) 4-s ] (wherein Y represents a phenyl group or a biphenylyl group. Phf represents at least one hydrogen atom, A phenyl group substituted with at least one selected from a perfluoroalkyl group, a perfluoroalkoxy group, and a halogen atom (s is an integer of 0 to 3), BF 4 , [(Rf) t PF 6-t ] - (Rf: an alkyl group in which 80% or more of hydrogen atoms are substituted with fluorine atoms, t: an integer of 0 to 5), AsF 6 , SbF 6 , SbF 5 OH − and the like. it can.
 光カチオン重合開始剤としては、例えば、(4-ヒドロキシフェニル)メチルベンジルスルホニウム テトラキス(ペンタフルオロフェニル)ボレート、4-(4-ビフェニリルチオ)フェニル-4-ビフェニリルフェニルスルホニウム テトラキス(ペンタフルオロフェニル)ボレート、4-(フェニルチオ)フェニルジフェニルスルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート、[4-(4-ビフェニリルチオ)フェニル]-4-ビフェニリルフェニルスルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート、ジフェニル[4-(フェニルチオ)フェニルスルホニウム] ヘキサフルオロアンチモネート、ジフェニル[4-(フェニルチオ)フェニル]スルホニウム トリス(ペンタフルオロエチル)トリフルオロホスフェート、ジフェニル[4-(フェニルチオ)フェニル]スルホニウム テトラキス(ペンタフルオロフェニル)ボレート、ジフェニル[4-(フェニルチオ)フェニル]スルホニウム ヘキサフルオロホスフェート、4-(4-ビフェニリルチオ)フェニル-4-ビフェニリルフェニルスルホニウム トリス(ペンタフルオロエチル)トリフルオロホスフェート、ビス[4-(ジフェニルスルホニオ)フェニル]スルフィド フェニルトリス(ペンタフルオロフェニル)ボレート、[4-(2-チオキサントニルチオ)フェニル]フェニル-2-チオキサントニルスルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート、商品名「サイラキュアUVI-6970」、「サイラキュアUVI-6974」、「サイラキュアUVI-6990」、「サイラキュアUVI-950」(以上、米国ユニオンカーバイド社製)、「Irgacure250」、「Irgacure261」、「Irgacure264」、「CG-24-61」(以上、BASF社製)、「オプトマーSP-150」、「オプトマーSP-151」、「オプトマーSP-170」、「オプトマーSP-171」(以上、(株)ADEKA製)、「DAICAT II」((株)ダイセル製)、「UVAC1590」、「UVAC1591」(以上、ダイセル・オルネクス(株)製)、「CI-2064」、「CI-2639」、「CI-2624」、「CI-2481」、「CI-2734」、「CI-2855」、「CI-2823」、「CI-2758」、「CIT-1682」(以上、日本曹達(株)製)、「PI-2074」(ローディア社製、テトラキス(ペンタフルオロフェニル)ボレート トリルクミルヨードニウム塩)、「FFC509」(3M社製)、「BBI-102」、「BBI-101」、「BBI-103」、「MPI-103」、「TPS-103」、「MDS-103」、「DTS-103」、「NAT-103」、「NDS-103」(以上、ミドリ化学(株)製)、「CD-1010」、「CD-1011」、「CD-1012」(以上、米国、Sartomer社製)、「CPI-100P」、「CPI-101A」(以上、サンアプロ(株)製)等を挙げることができる。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。 Examples of the cationic photopolymerization initiator include (4-hydroxyphenyl) methylbenzylsulfonium tetrakis (pentafluorophenyl) borate, 4- (4-biphenylylthio) phenyl-4-biphenylylphenylsulfonium tetrakis (pentafluorophenyl) Borate, 4- (phenylthio) phenyldiphenylsulfonium phenyltris (pentafluorophenyl) borate, [4- (4-biphenylylthio) phenyl] -4-biphenylylphenylsulfonium phenyltris (pentafluorophenyl) borate, diphenyl [4 -(Phenylthio) phenylsulfonium] hexafluoroantimonate, diphenyl [4- (phenylthio) phenyl] sulfonium tris (pentafluoroethyl) to Fluorophosphate, diphenyl [4- (phenylthio) phenyl] sulfonium tetrakis (pentafluorophenyl) borate, diphenyl [4- (phenylthio) phenyl] sulfonium hexafluorophosphate, 4- (4-biphenylylthio) phenyl-4-biphenylyl Phenylsulfonium tris (pentafluoroethyl) trifluorophosphate, bis [4- (diphenylsulfonio) phenyl] sulfide Phenyltris (pentafluorophenyl) borate, [4- (2-thioxanthonylthio) phenyl] phenyl-2- Thioxanthonylsulfonium phenyltris (pentafluorophenyl) borate, trade names “Syracure UVI-6970”, “Syracure UVI-6974”, “Syra "Cure UVI-6990", "Syracure UVI-950" (manufactured by Union Carbide, USA), "Irgacure 250", "Irgacure 261", "Irgacure 264", "CG-24-61" (above, manufactured by BASF), " “Optomer SP-150”, “Optomer SP-151”, “Optomer SP-170”, “Optomer SP-171” (manufactured by ADEKA Corporation), “DAICAT II” (manufactured by Daicel Corporation), “UVAC1590” ", UVAC1591" (manufactured by Daicel Ornex Co., Ltd.), "CI-2064", "CI-2439", "CI-2624", "CI-2481", "CI-2734", "CI-" 2855 "," CI-2823 "," CI-2758 "," CIT-1682 " As described above, manufactured by Nippon Soda Co., Ltd.), “PI-2074” (manufactured by Rhodia, tetrakis (pentafluorophenyl) borate, trirucumyl iodonium salt), “FFC509” (manufactured by 3M), “BBI-102” “BBI-101”, “BBI-103”, “MPI-103”, “TPS-103”, “MDS-103”, “DTS-103”, “NAT-103”, “NDS-103” Chemical Co., Ltd.), "CD-1010", "CD-1011", "CD-1012" (above, manufactured by Sartomer, USA), "CPI-100P", "CPI-101A" (above, San Apro ( And the like). These can be used alone or in combination of two or more.
 (熱カチオン重合開始剤)
 熱カチオン重合開始剤は、加熱処理を施すことによって酸を発生して硬化性組成物に含まれるカチオン硬化性化合物の硬化反応を開始させる化合物であり、熱を吸収するカチオン部と酸の発生源となるアニオン部からなる。
(Thermal cationic polymerization initiator)
The thermal cationic polymerization initiator is a compound that generates an acid by heat treatment and initiates a curing reaction of the cationic curable compound contained in the curable composition, and a cationic part that absorbs heat and a source of the acid It consists of an anion part.
 熱カチオン重合開始剤としては、例えば、ヨードニウム塩系化合物、スルホニウム塩系化合物等を挙げることができる。 Examples of the thermal cationic polymerization initiator include iodonium salt compounds and sulfonium salt compounds.
 熱カチオン重合開始剤のカチオン部としては、例えば、4-ヒドロキシフェニル-メチル-ベンジルスルホニウムイオン、4-ヒドロキシフェニル-メチル-(2-メチルベンジル)スルホニウムイオン、4-ヒドロキシフェニル-メチル-1-ナフチルメチルスルホニウムイオン、p-メトキシカルボニルオキシフェニル-ベンジル-メチルスルホニウムイオン等を挙げることができる。 Examples of the cationic part of the thermal cationic polymerization initiator include 4-hydroxyphenyl-methyl-benzylsulfonium ion, 4-hydroxyphenyl-methyl- (2-methylbenzyl) sulfonium ion, 4-hydroxyphenyl-methyl-1-naphthyl. Examples include methylsulfonium ion and p-methoxycarbonyloxyphenyl-benzyl-methylsulfonium ion.
 熱カチオン重合開始剤のアニオン部としては、上記光カチオン重合開始剤のアニオン部と同様の例を挙げることができる。 Examples of the anion portion of the thermal cationic polymerization initiator include the same examples as the anion portion of the photocationic polymerization initiator.
 熱カチオン重合開始剤としては、例えば、4-ヒドロキシフェニル-メチル-ベンジルスルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート、4-ヒドロキシフェニル-メチル-(2-メチルベンジル)スルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート、4-ヒドロキシフェニル-メチル-1-ナフチルメチルスルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート、p-メトキシカルボニルオキシフェニル-ベンジル-メチルスルホニウム フェニルトリス(ペンタフルオロフェニル)ボレート等を挙げることができる。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。 Examples of the thermal cationic polymerization initiator include 4-hydroxyphenyl-methyl-benzylsulfonium phenyltris (pentafluorophenyl) borate, 4-hydroxyphenyl-methyl- (2-methylbenzyl) sulfonium phenyltris (pentafluorophenyl) borate 4-hydroxyphenyl-methyl-1-naphthylmethylsulfonium, phenyltris (pentafluorophenyl) borate, p-methoxycarbonyloxyphenyl-benzyl-methylsulfonium, phenyltris (pentafluorophenyl) borate, and the like. These can be used alone or in combination of two or more.
 (硬化剤)
 本発明における硬化剤は、加熱処理を施すことにより、エポキシ基(特に、脂環エポキシ基)を有する化合物と反応して架橋構造を形成する化合物であり、例えば、酸無水物、イミダゾール化合物、アミン化合物、ポリアミド樹脂、ポリスルフィド樹脂、潜在性硬化剤等を挙げることができる。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。
(Curing agent)
The curing agent in the present invention is a compound that reacts with a compound having an epoxy group (particularly, an alicyclic epoxy group) to form a crosslinked structure by heat treatment. For example, an acid anhydride, an imidazole compound, an amine Examples thereof include compounds, polyamide resins, polysulfide resins, and latent curing agents. These can be used alone or in combination of two or more.
 前記酸無水物としては、例えば、メチルテトラヒドロ無水フタル酸、メチルヘキサヒドロ無水フタル酸、ドデセニル無水コハク酸、メチルエンドメチレンテトラヒドロ無水フタル酸、水素化メチルナジック酸無水物、メチルハイミック酸無水物、トリアルキルテトラヒドロ無水フタル酸マレイン酸付加物、無水フタル酸、テトラヒドロ無水フタル酸、ヘキサヒドロ無水フタル酸、メチルシクロヘキセンジカルボン酸無水物、及びこれらの誘導体(例えば、環にアルキル基等の置換基が結合したものなど)などを挙げることができる。 Examples of the acid anhydride include methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, dodecenyl succinic anhydride, methylendomethylenetetrahydrophthalic anhydride, hydrogenated methylnadic acid anhydride, methylheimic acid anhydride, Trialkyltetrahydrophthalic anhydride maleic acid adduct, phthalic anhydride, tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methylcyclohexenedicarboxylic anhydride, and derivatives thereof (for example, a substituent such as an alkyl group is bonded to the ring) Etc.).
 酸無水物としては、なかでも、硬化物の透明性や耐光性の点で、飽和単環炭化水素ジカルボン酸の無水物又はその誘導体が好ましい。また、硬化性組成物の取り扱い性の点では、25℃で液状の酸無水物(例えば、水素化メチルナジック酸無水物、メチルテトラヒドロ無水フタル酸、メチルヘキサヒドロ無水フタル酸、ドデセニル無水コハク酸、メチルエンドメチレンテトラヒドロ無水フタル酸など)が好ましく、特に、水素化メチルナジック酸無水物が好ましい。なお、25℃で固体の酸無水物(例えば、無水フタル酸、テトラヒドロ無水フタル酸、ヘキサヒドロ無水フタル酸、メチルシクロヘキセンジカルボン酸無水物など)であっても、上述の25℃で液状の酸無水物と混合して液状の組成物(硬化剤組成物)とすることにより、酸無水物としての取り扱い性を向上させることが可能である。 As the acid anhydride, an anhydride of a saturated monocyclic hydrocarbon dicarboxylic acid or a derivative thereof is particularly preferable from the viewpoint of transparency and light resistance of the cured product. In addition, in terms of handleability of the curable composition, an acid anhydride that is liquid at 25 ° C. (for example, hydrogenated methylnadic acid anhydride, methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, dodecenyl succinic anhydride, Methyl endomethylenetetrahydrophthalic anhydride and the like are preferable, and hydrogenated methyl nadic acid anhydride is particularly preferable. In addition, even if it is a solid acid anhydride (for example, phthalic anhydride, tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methylcyclohexene dicarboxylic acid anhydride, etc.) at 25 ° C., the acid anhydride that is liquid at 25 ° C. It is possible to improve the handleability as an acid anhydride by mixing with a liquid composition (curing agent composition).
 酸無水物としては、例えば、商品名「リカシッド MH-700」(新日本理化(株)製)、商品名「リカシッド MH-700F」(新日本理化(株)製)、商品名「HN-5500」(日立化成工業(株)製)などの市販品を使用することができる。 Examples of the acid anhydride include a product name “Licacid MH-700” (manufactured by Shin Nippon Rika Co., Ltd.), a product name “Rikacid MH-700F” (manufactured by Shin Nippon Rika Co., Ltd.) and a product name “HN-5500 ”(Manufactured by Hitachi Chemical Co., Ltd.) can be used.
 前記イミダゾール化合物としては、例えば、2-メチルイミダゾール、2-エチル-4-メチルイミダゾール、1-シアノエチル-2-ウンデシルイミダゾリウム・トルメリテート等を挙げることができる。 Examples of the imidazole compound include 2-methylimidazole, 2-ethyl-4-methylimidazole, 1-cyanoethyl-2-undecylimidazolium tolmellitate, and the like.
 前記アミン化合物としては、例えば、ピペリジン、N,N-ジメチルピペラジン、トリエチレンジアミン、2,4,6-トリス(ジメチルアミノメチル)フェノール、ベンジルジメチルアミン、2-(ジメチルアミノメチル)フェノール、ジエチレントリアミン、ジエチルアミノプロピルアミン、キシレンジアミン、メタフェニレンジアミン、ジアミノジフェニルメタン、ジアミノジフェニルスルフォン等を挙げることができる。 Examples of the amine compound include piperidine, N, N-dimethylpiperazine, triethylenediamine, 2,4,6-tris (dimethylaminomethyl) phenol, benzyldimethylamine, 2- (dimethylaminomethyl) phenol, diethylenetriamine, and diethylamino. Examples include propylamine, xylenediamine, metaphenylenediamine, diaminodiphenylmethane, and diaminodiphenylsulfone.
 前記潜在性硬化剤としては、例えば、三フッ化ホウ素-アミン錯体、ジシアンジアミド、有機酸ヒドラジッド、SbF6 -系芳香族スルホニウム塩(例えば、商品名「サンエイドSI-100L」、「サンエイドSI-60L」、「サンエイドSI-80L」、「サンエイドSI-110」、「サンエイドSI-180」、以上、三新化学工業(株)製)等を挙げることができる。 As the latent curing agent, e.g., boron trifluoride - amine complex, dicyandiamide, organic acid hydrazide, SbF 6 - aromatic sulfonium salts (e.g., trade name "San-Aid SI-100L", "San-Aid SI-60L" , “Sun-Aid SI-80L”, “Sun-Aid SI-110”, “Sun-Aid SI-180”, Sanshin Chemical Industry Co., Ltd.) and the like.
 (硬化促進剤)
 本発明における硬化促進剤は、エポキシ基(特に、脂環エポキシ基)を有する化合物と硬化剤との反応を促進し、より穏和な温度で速やかに硬化させる作用を発揮する化合物であり、例えば、1,8-ジアザビシクロ[5.4.0]ウンデセン-7(DBU)、1,5-ジアザビシクロ[4.3.0]ノネン-5(DBN)、及びこれらの塩(例えば、フェノール塩、オクチル酸塩、p-トルエンスルホン酸塩、ギ酸塩、テトラフェニルボレート塩);ベンジルジメチルアミン、2,4,6-トリス(ジメチルアミノメチル)フェノール、N,N-ジメチルシクロヘキシルアミン等の第3級アミン;2-エチル-4-メチルイミダゾール、1-シアノエチル-2-エチル-4-メチルイミダゾール等のイミダゾール;リン酸エステル、トリフェニルホスフィン等のホスフィン類;テトラフェニルホスホニウムブロミド、テトラブチルホスホニウムブロミド、テトラフェニルホスホニウムヨージド、エチルトリフェニルホスホニウムヨージド等のホスホニウム化合物等を挙げることができる。これらは1種を単独で、又は2種以上を組み合わせて使用することができる。
(Curing accelerator)
The curing accelerator in the present invention is a compound that promotes the reaction between a curing agent and a compound having an epoxy group (particularly an alicyclic epoxy group), and exhibits an effect of quickly curing at a milder temperature. 1,8-diazabicyclo [5.4.0] undecene-7 (DBU), 1,5-diazabicyclo [4.3.0] nonene-5 (DBN), and salts thereof (eg, phenol salts, octylic acid) Salt, p-toluenesulfonate, formate, tetraphenylborate salt); tertiary amines such as benzyldimethylamine, 2,4,6-tris (dimethylaminomethyl) phenol, N, N-dimethylcyclohexylamine; Imidazoles such as 2-ethyl-4-methylimidazole and 1-cyanoethyl-2-ethyl-4-methylimidazole; Phosphines such as sulfonyl phosphine; tetraphenylphosphonium bromide, may be mentioned tetrabutylphosphonium bromide, tetraphenylphosphonium iodide, phosphonium compounds such as ethyltriphenylphosphonium iodide. These can be used alone or in combination of two or more.
 硬化促進剤としては、例えば、商品名「U-CAT SA 506」、「U-CAT SA 102」、「U-CAT 5003」、「U-CAT 18X」、「U-CAT 12XD」(開発品)(以上、サンアプロ(株)製)、「TPP-K」、「TPP-MK」(以上、北興化学工業(株)製)、「PX-4ET」(日本化学工業(株)製)、「2E4MZ」(四国化成工業(株)製)等の市販品を使用することができる。 Examples of the curing accelerator include trade names “U-CAT SA 506”, “U-CAT SA 102”, “U-CAT 5003”, “U-CAT 18X”, “U-CAT 12XD” (developed product). (San Apro Co., Ltd.), TPP-K, TPP-MK (Hokuko Chemical Co., Ltd.), PX-4ET (Nippon Chemical Co., Ltd.), 2E4MZ ”(Manufactured by Shikoku Kasei Kogyo Co., Ltd.) can be used.
 本発明の硬化性組成物は上記成分以外にも必要に応じて他の成分を1種又は2種以上含有していても良い。他の成分としては、例えば、増感剤、増感助剤、酸化防止剤、安定化剤、界面活性剤、溶剤、レベリング剤、シランカップリング剤、充填材、重合禁止剤、光安定剤、可塑剤、消泡剤、発泡剤、紫外線吸収剤、イオン吸着体、顔料、蛍光体、離型剤等を挙げることができる。これらの含有量(2種以上含有する場合はその総量)は、硬化性組成物全量(100重量%)の、例えば0.05~10重量%程度、好ましくは0.1~5重量%である。 The curable composition of the present invention may contain one or more other components as necessary in addition to the above components. Examples of other components include sensitizers, sensitizers, antioxidants, stabilizers, surfactants, solvents, leveling agents, silane coupling agents, fillers, polymerization inhibitors, light stabilizers, Examples thereof include a plasticizer, an antifoaming agent, a foaming agent, an ultraviolet absorber, an ion adsorbent, a pigment, a phosphor, and a release agent. These contents (the total amount when two or more kinds are contained) are, for example, about 0.05 to 10% by weight, preferably 0.1 to 5% by weight, based on the total amount (100% by weight) of the curable composition. .
 本発明の硬化性組成物は、成分(A)と、必要に応じて、成分(B)、成分(C)、成分(D)、及び他の成分を、自公転式撹拌脱泡装置、ホモジナイザー、プラネタリーミキサー、3本ロールミル、ビーズミル等の一般的に知られる混合用機器を使用して均一に混合することにより製造することができる。尚、各成分は、同時に混合してもよいし、逐次混合してもよい。 The curable composition of the present invention comprises a component (A) and, if necessary, a component (B), a component (C), a component (D), and other components, a self-revolving stirring deaerator, a homogenizer , A planetary mixer, a three-roll mill, a bead mill, and the like. Each component may be mixed simultaneously or sequentially.
 成分(A)(好ましくは式(a)で表される化合物、特に好ましくは式(a-1)で表される化合物)の含有量(2種以上含有する場合はその総量)は、本発明の硬化性組成物に含まれる硬化性化合物全量(100重量%)の0.1~99.9量%であり、好ましくは1~95重量%、より好ましくは2~90重量%、特に好ましくは30~90重量%、最も好ましくは60~90重量%である。本発明の硬化性組成物が成分(A)を上記範囲で含有すると、硬化性に優れ、強靱性及び耐擦傷性、基材への接着性に優れた硬化物を形成することができる。一方、成分(A)の含有量が上記範囲を下回ると、基材への接着性が低下する傾向があり、成分(A)の含有量が上記範囲を上回ると、強靭性や耐擦傷性が低下する傾向がある。 The content of the component (A) (preferably the compound represented by the formula (a), particularly preferably the compound represented by the formula (a-1)) (the total amount when containing two or more) is the present invention. 0.1 to 99.9% by weight of the total amount (100% by weight) of the curable compound contained in the curable composition, preferably 1 to 95% by weight, more preferably 2 to 90% by weight, and particularly preferably 30 to 90% by weight, most preferably 60 to 90% by weight. When the curable composition of this invention contains a component (A) in the said range, it can be excellent in sclerosis | hardenability, toughness and abrasion resistance, and the hardened | cured material excellent in the adhesiveness to a base material can be formed. On the other hand, if the content of the component (A) is less than the above range, the adhesion to the substrate tends to decrease, and if the content of the component (A) exceeds the above range, the toughness and scratch resistance are high. There is a tendency to decrease.
 本発明の硬化性組成物は成分(A)と共に成分(B)(好ましくはエポキシ化合物、特に好ましくは脂環式エポキシ化合物、最も好ましくは脂環エポキシ基含有化合物)及び/又は成分(C)を含有することが好ましく、本発明の硬化性組成物に含まれる硬化性化合物全量(100重量%)に占める成分(B)と成分(C)の合計含有量の割合は、例えば0.1~99.9重量%、好ましくは5~99重量%、より好ましくは10~98重量%、特に好ましくは10~70重量%、最も好ましくは10~40重量%である。また、本発明の硬化性組成物における成分(A)の含有量と、成分(B)と成分(C)の合計含有量の重量比[成分(A)/(成分(B)+成分(C))]は、例えば95/5~60/40、好ましくは95/5~70/30、特に好ましくは90/10~75/25である。本発明の硬化性組成物が成分(A)、成分(B)、及び成分(C)を上記範囲で含有すると、硬化性に優れ、強靱性及び耐擦傷性に優れた硬化物を形成することができる。成分(B)及び/又は成分(C)の含有量が上記範囲を下回ると、すなわち成分(A)の含有量が上記範囲を上回ると、強靭性や耐擦傷性が低下する傾向がある。一方、成分(B)及び/又は成分(C)の含有量が上記範囲を上回ると、すなわち成分(A)の含有量が上記範囲を下回ると、基材への接着性が低下する傾向がある。 The curable composition of the present invention comprises component (A) and component (B) (preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound) and / or component (C). The total content of component (B) and component (C) in the total amount (100% by weight) of the curable compound contained in the curable composition of the present invention is, for example, 0.1 to 99. 0.9 wt%, preferably 5 to 99 wt%, more preferably 10 to 98 wt%, particularly preferably 10 to 70 wt%, and most preferably 10 to 40 wt%. The weight ratio of the content of component (A) in the curable composition of the present invention and the total content of component (B) and component (C) [component (A) / (component (B) + component (C ))] Is, for example, 95/5 to 60/40, preferably 95/5 to 70/30, particularly preferably 90/10 to 75/25. When the curable composition of the present invention contains the component (A), the component (B), and the component (C) in the above range, a cured product having excellent curability and excellent toughness and scratch resistance is formed. Can do. When the content of the component (B) and / or the component (C) is below the above range, that is, when the content of the component (A) exceeds the above range, the toughness and scratch resistance tend to decrease. On the other hand, when the content of the component (B) and / or the component (C) exceeds the above range, that is, when the content of the component (A) is below the above range, the adhesion to the substrate tends to decrease. .
 また、本発明の硬化性組成物に含まれる硬化性化合物全量(100重量%)における成分(B)(好ましくはエポキシ化合物、特に好ましくは脂環式エポキシ化合物、最も好ましくは脂環エポキシ基含有化合物)の含有量(2種以上含有する場合はその総量)は、例えば0.1~99.9重量%、好ましくは5~99重量%、より好ましくは10~90重量%、特に好ましくは10~70重量%、最も好ましくは10~40重量%である。 In addition, component (B) (preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound) in the total amount (100% by weight) of the curable compound contained in the curable composition of the present invention. ) (When two or more types are contained, the total amount thereof) is, for example, 0.1 to 99.9% by weight, preferably 5 to 99% by weight, more preferably 10 to 90% by weight, and particularly preferably 10 to 90% by weight. 70% by weight, most preferably 10-40% by weight.
 更に、本発明の硬化性組成物に含まれる成分(B)(好ましくはエポキシ化合物、特に好ましくは脂環式エポキシ化合物、最も好ましくは脂環エポキシ基含有化合物)及び成分(C)の合計含有量における、成分(B)の占める割合は、例えば60重量%以上、好ましくは80重量%以上、特に好ましくは90重量%以上である。 Furthermore, the total content of component (B) (preferably an epoxy compound, particularly preferably an alicyclic epoxy compound, most preferably an alicyclic epoxy group-containing compound) and component (C) contained in the curable composition of the present invention. The proportion of component (B) in is, for example, 60% by weight or more, preferably 80% by weight or more, and particularly preferably 90% by weight or more.
 本発明の硬化性組成物に含まれる硬化性化合物全量(100重量%)に占める成分(A)と成分(B)と成分(C)の合計含有量の割合は、例えば60重量%以上、好ましくは70重量%以上、特に好ましくは80重量%以上、最も好ましくは90重量%以上、とりわけ好ましくは95重量%以上である。尚、上限は100重量%である。すなわち、本発明の硬化性組成物は、成分(A)と成分(B)と成分(C)以外の硬化性化合物を含有していても良いが、その含有量は、硬化性化合物全量(100重量%)の、例えば40重量%以下、好ましくは30重量%以下、特に好ましくは20重量%以下、最も好ましくは10重量%以下、とりわけ好ましくは5重量%以下である。 The ratio of the total content of component (A), component (B) and component (C) in the total amount (100% by weight) of the curable compound contained in the curable composition of the present invention is, for example, 60% by weight or more, preferably Is 70% by weight or more, particularly preferably 80% by weight or more, most preferably 90% by weight or more, and particularly preferably 95% by weight or more. The upper limit is 100% by weight. That is, although the curable composition of this invention may contain curable compounds other than a component (A), a component (B), and a component (C), the content is curable compound whole quantity (100 % By weight), for example, 40% by weight or less, preferably 30% by weight or less, particularly preferably 20% by weight or less, most preferably 10% by weight or less, and particularly preferably 5% by weight or less.
 本発明の硬化性組成物が重合開始剤を含有する場合におけるラジカル重合開始剤の含有量(2種以上含有する場合はその総量)は、本発明の硬化性組成物に含まれるラジカル硬化性基を有する化合物の総量(好ましくは、成分(A)と成分(C)の総量)100重量部に対して、例えば0.1~10.0重量部、好ましくは0.1~5.0重量部、特に好ましくは0.2~3.0重量部、最も好ましくは0.2~1.0重量部であり、より具体的には、硬化性組成物中に含有する全てのラジカル硬化性基を有する化合物におけるラジカル硬化性基(好ましくは、(メタ)アクリロイルオキシ基)1当量当たり、0.001~0.1当量となる割合で含有することが好ましい。 The content of the radical polymerization initiator in the case where the curable composition of the present invention contains a polymerization initiator (the total amount when containing two or more kinds) is the radical curable group contained in the curable composition of the present invention. For example, 0.1 to 10.0 parts by weight, preferably 0.1 to 5.0 parts by weight, per 100 parts by weight of the total amount of the compound having (preferably, the total amount of component (A) and component (C)) Particularly preferably 0.2 to 3.0 parts by weight, and most preferably 0.2 to 1.0 parts by weight. More specifically, all radical curable groups contained in the curable composition are contained. It is preferable to contain it in a proportion of 0.001 to 0.1 equivalent per equivalent of radical curable group (preferably (meth) acryloyloxy group) in the compound.
 また、本発明の硬化性組成物が重合開始剤を含有する場合におけるカチオン重合開始剤の含有量(2種以上含有する場合はその総量)は、硬化性組成物に含まれるカチオン硬化性基を有する化合物の総量(好ましくは、成分(A)と成分(B)の総量)100重量部に対して、例えば0.1~10.0重量部、好ましくは0.1~5.0重量部、特に好ましくは0.2~3.0重量部、最も好ましくは0.2~1.0重量部であり、より具体的には、硬化性組成物中に含有する全てのカチオン硬化性基を有する化合物におけるカチオン硬化性基(好ましくは、エポキシ基)1当量当たり、0.0001~0.1当量となる割合で含有することが好ましい。カチオン重合開始剤の含有量が上記範囲を下回ると、硬化性が低下する傾向がある。一方、カチオン重合開始剤の含有量が上記範囲を上回ると、特に本発明の硬化性組成物が光硬化性組成物である場合において、得られる硬化物に内部硬化不良が発生し易くなる傾向がある。 In addition, the content of the cationic polymerization initiator in the case where the curable composition of the present invention contains a polymerization initiator (the total amount when containing two or more types) is the cationic curable group contained in the curable composition. For example, 0.1 to 10.0 parts by weight, preferably 0.1 to 5.0 parts by weight, with respect to 100 parts by weight of the total amount of compounds (preferably the total amount of component (A) and component (B)) Particularly preferred is 0.2 to 3.0 parts by weight, and most preferred is 0.2 to 1.0 part by weight. More specifically, it has all the cationic curable groups contained in the curable composition. It is preferably contained in a proportion of 0.0001 to 0.1 equivalent per equivalent of cationically curable group (preferably epoxy group) in the compound. When content of a cationic polymerization initiator is less than the said range, there exists a tendency for sclerosis | hardenability to fall. On the other hand, when the content of the cationic polymerization initiator exceeds the above range, particularly when the curable composition of the present invention is a photocurable composition, internal cured defects tend to occur easily in the obtained cured product. is there.
 本発明の硬化性組成物が硬化剤としての酸無水物を含有する場合における酸無水物の含有量(2種以上含有する場合はその総量)は、硬化性組成物中に含有するカチオン硬化性基を有する化合物の総量(好ましくは、成分(A)と成分(B)の総量)100重量部に対して、例えば50~200重量部、好ましくは100~145重量部、より具体的には、硬化性組成物中に含有する全てのカチオン硬化性基を有する化合物におけるカチオン硬化性基(好ましくは、エポキシ基)1当量当たり、酸無水物基が0.5~1.5当量となる割合で含有することが好ましい。酸無水物の含有量が50重量部を下回ると、硬化が不十分となり、得られる硬化物の強靱性が低下する傾向がある。一方、酸無水物の含有量が200重量部を上回ると、硬化物が着色して色相が悪化する場合がある。 In the case where the curable composition of the present invention contains an acid anhydride as a curing agent, the content of the acid anhydride (the total amount when two or more types are contained) is the cation curable contained in the curable composition. For example, 50 to 200 parts by weight, preferably 100 to 145 parts by weight, more specifically, with respect to 100 parts by weight of the total amount of the compound having a group (preferably the total amount of component (A) and component (B)) The ratio of the acid anhydride group to 0.5 to 1.5 equivalents per equivalent of the cationically curable group (preferably epoxy group) in the compound having all the cationic curable groups contained in the curable composition. It is preferable to contain. When the content of the acid anhydride is less than 50 parts by weight, the curing becomes insufficient and the toughness of the resulting cured product tends to decrease. On the other hand, if the content of the acid anhydride exceeds 200 parts by weight, the cured product may be colored to deteriorate the hue.
 本発明の硬化性組成物が硬化剤としての潜在性硬化剤を含有する場合における潜在性硬化剤の含有量(2種以上含有する場合はその総量)は、硬化性組成物中に含有するカチオン硬化性基を有する化合物の総量(好ましくは、成分(A)と成分(B)の総量)100重量部に対して、例えば0.1~5重量部、好ましくは0.5~5重量部、特に好ましくは1~5重量部である。潜在性硬化剤の含有量が0.1重量部を下回ると、硬化が不十分となり、得られる硬化物の強靱性が低下する傾向がある。一方、潜在性硬化剤の含有量が5重量部を上回ると、硬化物が着色して色相が悪化する場合がある。 In the case where the curable composition of the present invention contains a latent curing agent as a curing agent, the content of the latent curing agent (the total amount when containing two or more types) is the cation contained in the curable composition. For example, 0.1 to 5 parts by weight, preferably 0.5 to 5 parts by weight with respect to 100 parts by weight of the total amount of the compound having a curable group (preferably, the total amount of component (A) and component (B)) Particularly preferred is 1 to 5 parts by weight. When the content of the latent curing agent is less than 0.1 parts by weight, curing becomes insufficient, and the toughness of the obtained cured product tends to decrease. On the other hand, if the content of the latent curing agent exceeds 5 parts by weight, the cured product may be colored to deteriorate the hue.
 また、本発明の硬化性組成物が硬化剤を含有する場合は、硬化促進剤も共に含有することが好ましく、硬化促進剤の含有量(2種以上含有する場合はその総量)は、硬化性組成物中に含有するカチオン硬化性基を有する化合物の総量(好ましくは、成分(A)と成分(B)の総量)100重量部に対して、例えば0.05~5重量部、好ましくは0.1~3重量部、より好ましくは0.2~3重量部、特に好ましくは0.2~2.5重量部、最も好ましくは0.2~1.0重量部である。硬化促進剤を0.05重量部以上の範囲で含有すると、優れた硬化促進効果が得られる。また、硬化促進剤を5重量部以下の範囲で含有すると、硬化物の着色を抑制し、色相が良好な硬化物が得られる。 Moreover, when the curable composition of this invention contains a hardening | curing agent, it is preferable to also contain a hardening accelerator, and content of the hardening accelerator (the total amount when it contains 2 or more types) is curable. For example, 0.05 to 5 parts by weight, preferably 0 with respect to 100 parts by weight of the total amount of compounds having a cationically curable group contained in the composition (preferably the total amount of components (A) and (B)) 0.1 to 3 parts by weight, more preferably 0.2 to 3 parts by weight, particularly preferably 0.2 to 2.5 parts by weight, and most preferably 0.2 to 1.0 parts by weight. When the curing accelerator is contained in the range of 0.05 parts by weight or more, an excellent curing acceleration effect can be obtained. Moreover, when a hardening accelerator is contained in 5 weight part or less, coloring of hardened | cured material will be suppressed and hardened | cured material with a favorable hue will be obtained.
 本発明の硬化性組成物は硬化性に優れ、光照射又は加熱処理を施すことにより速やかに硬化物を形成することができる。 The curable composition of the present invention is excellent in curability and can quickly form a cured product by light irradiation or heat treatment.
 本発明の硬化性組成物が光硬化性組成物である場合は、紫外線のような活性エネルギー線を照射することにより硬化物を形成することができる。活性エネルギー線としては、紫外線以外にも、例えば可視光線、赤外線、X線、α線、β線、γ線、電子線等を使用することができる。照射条件は、塗布された硬化性組成物の膜厚等に応じて適宜変えることができる。活性エネルギー線の波長としては、通常200~600nmの範囲内が適当であり、光カチオン重合開始剤の種類等に応じて、感度の高い波長を適宜選択して使用することができる。 When the curable composition of the present invention is a photocurable composition, a cured product can be formed by irradiating active energy rays such as ultraviolet rays. As the active energy ray, in addition to ultraviolet rays, for example, visible rays, infrared rays, X rays, α rays, β rays, γ rays, electron rays, and the like can be used. Irradiation conditions can be appropriately changed according to the thickness of the applied curable composition. The wavelength of the active energy ray is usually in the range of 200 to 600 nm, and a wavelength with high sensitivity can be appropriately selected and used according to the type of the photocationic polymerization initiator.
 活性エネルギー線として紫外線を照射する場合、紫外線の照射源としては、例えば、高圧水銀ランプ、超高圧水銀ランプ、キセノンランプ、カーボンアーク、メタルハタイドランプ、太陽光等を使用できる。照射量は、線量が50~2000mJ/cm2となる範囲内が好ましい。 When irradiating ultraviolet rays as active energy rays, for example, a high-pressure mercury lamp, an ultra-high pressure mercury lamp, a xenon lamp, a carbon arc, a metal halide lamp, sunlight, or the like can be used as the ultraviolet irradiation source. The irradiation amount is preferably within a range where the dose is 50 to 2000 mJ / cm 2 .
 活性エネルギー線照射後、必要に応じて加熱処理を施してもよい。加熱処理を施すことによって硬化性組成物中の未反応物を低減することができ、成形加工の場合は、成形加工によって発生した歪みを緩和することもできる。上記加熱は、例えば100~200℃の雰囲気温度で1~120分間の条件で行うことができる。 ¡After irradiation with active energy rays, heat treatment may be performed as necessary. By applying the heat treatment, unreacted substances in the curable composition can be reduced, and in the case of molding, distortion generated by the molding can be reduced. The heating can be performed, for example, at an ambient temperature of 100 to 200 ° C. for 1 to 120 minutes.
 本発明の硬化性組成物が熱硬化性組成物である場合は、加熱処理を施すことにより硬化物を形成することができる。加熱処理温度は例えば40~250℃、加熱処理時間は例えば30分~12時間である。また、加熱処理は、同一温度で行ってもよく、段階的に温度を変化させて行ってもよい。 When the curable composition of the present invention is a thermosetting composition, a cured product can be formed by heat treatment. The heat treatment temperature is, for example, 40 to 250 ° C., and the heat treatment time is, for example, 30 minutes to 12 hours. Further, the heat treatment may be performed at the same temperature, or may be performed by changing the temperature stepwise.
 本発明の硬化性組成物の硬化物は強靱性、耐擦傷性に優れ、鉛筆硬度(鉛筆硬度試験;JIS K 5600-5-4準拠)は、例えばH以上、好ましくは2H以上である。 The cured product of the curable composition of the present invention is excellent in toughness and scratch resistance, and the pencil hardness (pencil hardness test; conforming to JIS K 5600-5-4) is, for example, H or more, preferably 2H or more.
 本発明の硬化性組成物は上記の通り硬化性に優れ、光照射及び/又は加熱処理を施すことにより速やかに硬化して、強靱性及び耐擦傷性に優れた硬化物を形成することができる。そのため、本発明の硬化性組成物は、例えば、塗料、インク(例えば、3Dプリンター用インク)、接着剤、封止剤(例えば、光半導体用封止剤)、LSIや多層プリント配線板に用いられる層間絶縁膜形成材、タッチパネル用粘着シート形成材、プリプレグ形成材、サイジング剤、炭素繊維強化樹脂用マトリックス樹脂、レジスト、シーラント、光学材料(たとえば、積層板、透明基材、透明シート、透明フィルム、光学素子(例えば、光学レンズ)、光造形、電子ペーパー、タッチパネル、太陽電池基板、光導波路、導光板、ホログラフィックメモリ等の形成材料)などの幅広い用途に使用することができる。 The curable composition of the present invention is excellent in curability as described above, and can be quickly cured by light irradiation and / or heat treatment to form a cured product having excellent toughness and scratch resistance. . Therefore, the curable composition of the present invention is used for, for example, paints, inks (for example, 3D printer ink), adhesives, sealants (for example, optical semiconductor sealants), LSIs, and multilayer printed wiring boards. Interlayer insulating film forming material, adhesive sheet forming material for touch panel, prepreg forming material, sizing agent, matrix resin for carbon fiber reinforced resin, resist, sealant, optical material (for example, laminate, transparent substrate, transparent sheet, transparent film) , Optical elements (for example, optical lenses), stereolithography, electronic paper, touch panels, solar cell substrates, optical waveguides, light guide plates, holographic memory, etc., can be used in a wide range of applications.
 [炭素繊維用サイジング剤]
 本発明のサイジング剤は、成分(A)を少なくとも含有する上述の硬化性組成物からなる。本発明のサイジング剤は、前記構成を有するため、炭素繊維とマトリックス樹脂の界面接着性に優れ、本発明のサイジング剤を炭素繊維に塗布し、その後硬化することにより、炭素繊維に優れた強靱性と耐擦傷性を、優れた作業性で、効率よく付与することができる。
[Carbon fiber sizing agent]
The sizing agent of this invention consists of the above-mentioned curable composition containing a component (A) at least. Since the sizing agent of the present invention has the above-described configuration, it has excellent interfacial adhesion between the carbon fiber and the matrix resin, and by applying the sizing agent of the present invention to the carbon fiber and then curing, the toughness excellent in the carbon fiber. And scratch resistance can be efficiently imparted with excellent workability.
 以下、実施例により本発明をより具体的に説明するが、本発明はこれらの実施例により限定されるものではない。 Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited to these examples.
 実施例1
 下記表に記載の処方(単位:重量部)に従って硬化性組成物を調製した。得られた硬化性組成物を、膜厚が10μmになるように基材(リン酸クロム処理を施したアルミニウム板)に塗工し、高圧水銀ランプを使用して紫外線照射(線量;1100mJ/cm2)を行い、硬化塗膜(硬化物)を得た。得られた硬化塗膜の鉛筆硬度を、JIS K5600-5-4に準じた方法で評価した。
Example 1
A curable composition was prepared according to the formulation (unit: parts by weight) described in the following table. The obtained curable composition was applied to a base material (aluminum plate treated with chromium phosphate) so as to have a film thickness of 10 μm, and was irradiated with ultraviolet rays (dose; 1100 mJ / cm 2) using a high-pressure mercury lamp. 2 ) to obtain a cured coating film (cured product). The pencil hardness of the obtained cured coating film was evaluated by a method according to JIS K5600-5-4.
 実施例2~3、比較例1
 下記表に記載の処方に変更した以外は実施例1と同様に行って硬化性組成物を調製し、硬化塗膜を得た。尚、実施例2、3では紫外線照射に代えて、150℃で2時間の加熱処理を行った。
Examples 2-3 and Comparative Example 1
A curable composition was prepared in the same manner as in Example 1 except that the formulation shown in the following table was changed to obtain a cured coating film. In Examples 2 and 3, heat treatment was performed at 150 ° C. for 2 hours instead of ultraviolet irradiation.
 上記結果を下記表に示す。
Figure JPOXMLDOC01-appb-T000009
The results are shown in the table below.
Figure JPOXMLDOC01-appb-T000009
<異官能基を有する化合物>
EDCPA:下記式(a-1-1)で表される、3,4-エポキシトリシクロ[5.2.1.02,6]デカン-9-イルアクリレート、商品名「E-DCPA」、(株)ダイセル製
Figure JPOXMLDOC01-appb-C000010
GMA:グリシジルメタクリレート、商品名「ブレンマーG」、日油(株)製
<エポキシ化合物>
セロキサイド2021P:3,4-エポキシシクロヘキシルメチル(3,4-エポキシ)シクロヘキサンカルボキシレート、商品名「セロキサイド2021P」、(株)ダイセル製
<重合開始剤>
Irgacure184:光ラジカル重合開始剤、1-ヒドロキシ-シクロヘキシルフェニルケトン、商品名「Irgacure184」、BASF社製
CPI-101A:光カチオン重合開始剤、ジフェニル[4-(フェニルチオ)フェニル]スルホニウム ヘキサフルオロホスフェート、商品名「CPI-101A」、サンアプロ(株)製
<硬化剤>
SI-100L:潜在性硬化剤、SbF6 -系芳香族スルホニウム塩、商品名「サンエイドSI-100L」、三新化学工業(株)製
リカシッドMH-700:酸無水物、4-メチルヘキサヒドロ無水フタル酸/ヘキサヒドロ無水フタル酸=70/30、商品名「リカシッドMH-700」、新日本理化(株)製
<硬化促進剤>
U-CAT 12XD:エポキシ樹脂硬化促進剤、特殊アミン、サンアプロ(株)製
2E4MZ:エポキシ樹脂硬化促進剤、2-エチル-4-メチルイミダゾール、四国化成工業(株)製
<Compounds having different functional groups>
EDCPA: 3,4-epoxytricyclo [5.2.1.0 2,6 ] decan-9-yl acrylate represented by the following formula (a-1-1), trade name “E-DCPA”, Made by Daicel Corporation
Figure JPOXMLDOC01-appb-C000010
GMA: Glycidyl methacrylate, trade name “Blenmer G”, manufactured by NOF Corporation <epoxy compound>
Celoxide 2021P: 3,4-epoxycyclohexylmethyl (3,4-epoxy) cyclohexanecarboxylate, trade name “Celoxide 2021P”, manufactured by Daicel Corporation <polymerization initiator>
Irgacure184: Photoradical polymerization initiator, 1-hydroxy-cyclohexyl phenyl ketone, trade name “Irgacure184”, BASF CPI-101A: Photocationic polymerization initiator, diphenyl [4- (phenylthio) phenyl] sulfonium hexafluorophosphate, product Name “CPI-101A”, manufactured by San Apro Co., Ltd.
SI-100L: latent curing agent, SbF 6 - aromatic sulfonium salt, trade name "San-Aid SI-100L", manufactured by Sanshin Chemical Industry Co., RIKACID MH-700: acid anhydride, 4-methylhexahydrophthalic anhydride Phthalic acid / hexahydrophthalic anhydride = 70/30, trade name “Licacid MH-700”, manufactured by Shin Nippon Rika Co., Ltd. <Curing Accelerator>
U-CAT 12XD: Epoxy resin curing accelerator, special amine, manufactured by San Apro Co., Ltd. 2E4MZ: Epoxy resin curing accelerator, 2-ethyl-4-methylimidazole, manufactured by Shikoku Kasei Kogyo Co., Ltd.
 本発明の硬化性組成物は硬化性に特に優れ、光照射又は加熱処理を施すことにより速やかに硬化して、強靱性、耐擦傷性に優れた硬化物を形成することができる。そのため、塗料、インク、接着剤、封止剤、LSIや多層プリント配線板に用いられる層間絶縁膜形成材、タッチパネル用粘着シート形成材、プリプレグ形成材、サイジング剤、炭素繊維強化樹脂用マトリックス樹脂等として好適に使用することができる。 The curable composition of the present invention is particularly excellent in curability, and can be quickly cured by light irradiation or heat treatment to form a cured product having excellent toughness and scratch resistance. Therefore, paints, inks, adhesives, sealants, interlayer insulating film forming materials used for LSIs and multilayer printed wiring boards, touch panel adhesive sheet forming materials, prepreg forming materials, sizing agents, matrix resins for carbon fiber reinforced resins, etc. Can be suitably used.

Claims (4)

  1.  硬化性化合物を含む硬化性組成物であって、前記硬化性化合物として、1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物を、硬化性組成物に含まれる硬化性化合物全量の0.1~99.9重量%含有する硬化性組成物。 A curable composition containing a curable compound, wherein the curable compound contains a compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule as the curable compound. A curable composition containing 0.1 to 99.9% by weight of
  2.  光又は熱硬化性組成物である、請求項1に記載の硬化性組成物。 The curable composition according to claim 1, which is a light or thermosetting composition.
  3.  1分子中に脂環エポキシ基と(メタ)アクリロイルオキシ基を有する化合物が、下記式(a-1)
    Figure JPOXMLDOC01-appb-C000001
    (式中、Xは単結合又は連結基を示し、R1は水素原子又はメチル基を示す)
    で表される化合物である請求項1又は2に記載の硬化性組成物。
    A compound having an alicyclic epoxy group and a (meth) acryloyloxy group in one molecule is represented by the following formula (a-1)
    Figure JPOXMLDOC01-appb-C000001
    (Wherein X represents a single bond or a linking group, and R 1 represents a hydrogen atom or a methyl group)
    The curable composition according to claim 1 or 2, which is a compound represented by the formula:
  4.  炭素繊維用サイジング剤である、請求項1~3の何れか1項に記載の硬化性組成物。 The curable composition according to any one of claims 1 to 3, which is a sizing agent for carbon fiber.
PCT/JP2017/008119 2016-03-02 2017-03-01 Curable composition WO2017150615A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016039842 2016-03-02
JP2016-039842 2016-03-02

Publications (1)

Publication Number Publication Date
WO2017150615A1 true WO2017150615A1 (en) 2017-09-08

Family

ID=59744155

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/008119 WO2017150615A1 (en) 2016-03-02 2017-03-01 Curable composition

Country Status (1)

Country Link
WO (1) WO2017150615A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01123817A (en) * 1987-11-09 1989-05-16 Kansai Paint Co Ltd Curable composition
JPH10310681A (en) * 1997-05-12 1998-11-24 Toyo Ink Mfg Co Ltd Radiation-curable resin composition and preparation thereof
JP2005226193A (en) * 2004-02-13 2005-08-25 Mitsubishi Rayon Co Ltd Sizing agent for reinforcing fiber, carbon fiber bundle, thermoplastic resin composition and molded product thereof
JP2013092759A (en) * 2011-10-07 2013-05-16 Sumitomo Chemical Co Ltd Colored photosensitive resin composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01123817A (en) * 1987-11-09 1989-05-16 Kansai Paint Co Ltd Curable composition
JPH10310681A (en) * 1997-05-12 1998-11-24 Toyo Ink Mfg Co Ltd Radiation-curable resin composition and preparation thereof
JP2005226193A (en) * 2004-02-13 2005-08-25 Mitsubishi Rayon Co Ltd Sizing agent for reinforcing fiber, carbon fiber bundle, thermoplastic resin composition and molded product thereof
JP2013092759A (en) * 2011-10-07 2013-05-16 Sumitomo Chemical Co Ltd Colored photosensitive resin composition

Similar Documents

Publication Publication Date Title
US20210206916A1 (en) Curable composition and cured product obtained by curing the same
WO2014061648A1 (en) Curable resin composition, and cured product thereof
TWI821172B (en) Adhesive composition for polarizing plates, adhesives for polarizing plates and polarizing plates utilizing the same
JP2010018797A (en) Curable composition for optical parts, adhesive agent for optical parts, and sealing agent for organic electroluminescence element
EP3375804B1 (en) Long-chain alkylene group-containing epoxy resin composition
JP7398960B2 (en) Resin composition for forming hard coat layer
EP3654074A1 (en) Fresnel lens and production method for same
WO2014196515A1 (en) Curable epoxy resin composition
JP2017228414A (en) Sealant for organic electroluminescent display element
JP5799177B2 (en) Light post-curing resin composition
JP2023156307A (en) Ultraviolet curable resin composition, manufacturing method of light emitting device, light emitting device, and touch panel
EP3431470B1 (en) Epoxy compound, curable composition, cured product, method for producing epoxy compound, and reactive diluent
KR20220038275A (en) Encapsulant for organic EL display elements
WO2014181787A1 (en) Curable epoxy resin composition and cured product thereof, diolefin compound and production method therefor, and production method for diepoxy compound
JP5310690B2 (en) Epoxy resin composition and cured epoxy resin
WO2017150615A1 (en) Curable composition
JP6251894B2 (en) Energy ray sensitive composition
JP5923485B2 (en) Manufacturing method of optical semiconductor device
JP2005263965A (en) New epoxy resin and curable resin composition containing the same
KR20220069877A (en) Photocurable resin composition for electronic devices
JP4243980B2 (en) 2,2-bis (3,4-epoxycyclohexyl) -1,1,1,3,3,3-hexafluoropropane and epoxy resin composition using the compound
US11613661B2 (en) Curable resin composition and manufacturing method of three-dimensional object using the same
JP2001261741A (en) Curable composition and method for forming coating film of the composition
JP7207973B2 (en) Curable resin composition
JPWO2017213205A1 (en) Epoxy compound, curable composition containing the same, and cured product obtained by curing curable composition

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17760079

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17760079

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP